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SUMMARY 
Natural killer (NK) cells represent the first lymphoid subpopulation in the defense against 
tumors and viral infection. The activity of NK cells is regulated by the interplay of 
activating and inhibitory surface receptors. The mechanisms by which these receptors 
transduce their signals and the integration of positive and negative signals are not 
completely understood. 2B4 (CD244) is an important activating NK cell receptor. Ligand 
engagement results in the recruitment of 2B4 to membrane microdomains, which is 
essential for the function of this receptor. 
Here we successfully established a new approach to investigate membrane microdomains 
without destroying the membrane’s natural composition, as it has often been criticized 
for the classical cold non-ionic detergent lysis followed by sucrose density gradient 
centrifugation. NK cell receptors were stimulated by antibodies coupled to magnetic 
beads. NK cells were then physically disrupted in a nitrogen-cavitation bomb and 
membrane fragments surrounding the engaged receptor including the associated 
signaling machinery were immunoisolated by separation of the magnetic beads. By 
comparing bead contents of activating (2B4) with inhibitory (NKG2A) NK cell receptors 
using 2D-DIGE, several proteins with significant difference emerged, which were 
subsequently identified by mass spectrometry. Important candidates for cytoskeletal 
remodeling and signal transduction were identified to be specifically associated with 2B4, 
which gave us a first hint for the formation of multimolecular complexes and their role in 
the early steps of NK cell activation. 
In a second project we analyzed the glycosylation of 2B4. We demonstrated that 2B4 is 
heavily and differentially glycosylated in primary human NK cells and NK cell lines. The 
differential glycosylation of 2B4 could be attributed to sialic acid residues on N- and O-
linked carbohydrates. Glycosylation plays an important role in receptor-ligand recognition 
and interaction but may also lead to repulsion between molecules. Using a recombinant 
fusion protein of the extracellular domain of 2B4 we demonstrated that N-linked 
glycosylation of 2B4 is essential for binding to its ligand CD48. In contrast, sialylation of 
2B4 had a negative impact on ligand binding as the interaction between 2B4 and CD48 
was increased after the removal of sialic acids. This was confirmed in a functional assay 
system, where the desialylation of NK cells or the inhibition of O-linked glycosylation 
resulted in increased 2B4-mediated lysis of CD48 expressing tumor target cells. These 
data demonstrate that glycosylation has an important impact on 2B4-mediated NK cell 
function and suggest that regulated changes in glycosylation during NK cell development 
and activation might be involved in the regulation of NK cell responses. 
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ZUSAMMENFASSUNG 
Natürliche Killer (NK) Zellen repräsentieren die erste lymphoide Subpopulation in der 
Immunabwehr gegen Tumore und virale Infektionen. Die Aktivität der NK Zellen wird 
durch eine Vielzahl von aktivierenden und inhibierenden Oberflächenrezeptoren reguliert. 
Die Signaltransduktion dieser Rezeptoren als auch das Zusammenpiel zwischen beiden 
Rezeptortypen ist bis heute noch nicht vollständig verstanden. 2B4 (CD244) ist ein 
aktivierender Rezeptor, der für die Regulation von NK Zellen von großer Bedeutung ist. 
Seine Aktivierung führt zur Rekrutierung in spezialisierte Membranbereiche, so genannte 
„lipid rafts“ oder Membran Mikrodomänen. Die klassische Methode zur Untersuchung 
dieser „lipid rafts“ beruht auf der Verwendung von kaltem, nicht-ionischen Detergenz mit 
anschließender Saccharose-Dichtegradientenzentrifugation.  
In dieser Arbeit wurde eine neue Technik zur Untersuchung von Membran Mikrodomänen 
etabliert, bei der es nicht zu einer Zerstörung der natürlichen Membran-
zusammensetzung kommt, was ein oft genannter Kritikpunkt für die Verwendung von 
Detergenzien ist. NK Zell Rezeptoren wurden durch Antikörper gebundene, magnetische 
Kügelchen stimuliert. Anschließend erfolgte die Zerstörung der Zelle mit Hilfe einer 
Stickstoff-Bombe sowie die Immunisolierung der Rezeptor umgebenden 
Membranfragmente inklusive angrenzenden Signalmoleküle durch magnetische 
Separierung der Kügelchen.  
Ein Vergleich der immunisolierten Proteine von aktivierenden (2B4) mit inhibierenden 
(NKG2A) NK Zell Rezeptoren mittels 2D-DIGE führte zur Entdeckung mehrerer Proteine, 
die spezifisch mit 2B4 assoziiert waren, und die anschließend durch Massenspektrometrie 
identifiziert wurden. Hierbei handelte es sich unter anderem um Proteine, die eine 
wichtige Aufgabe bei der Signaltransduktion oder bei der Umorganisation des 
Zytoskeletts erfüllen und somit einen ersten Einblick in den Aufbau multimolekularer 
Komplexe und deren Rolle zur NK Zell Regulierung geben. 
In einem zweiten Projekt untersuchten wir die Glykosylierung von 2B4 und konnten 
zeigen, dass 2B4 sowohl in NK Zelllinien als auch in primären NK Zellen differenziell 
glykosyliert ist. Die unterschiedliche Glykosylierung von 2B4 konnte auf an N- und O-
gebundene Sialinsäuren zurückgeführt werden. Glykosylierung spielt eine wichtige Rolle 
bei Rezeptor-Liganden Erkennung und deren Interaktion, kann aber auch zur Abstoßung 
von Molekülen führen. Durch die Verwendung eines rekombinanten Fusionsproteins 
konnten wir zeigen, dass N-verknüpfte Kohlenhydrate essentiell für die Bindung von 2B4 
an seinen Liganden CD48 sind. Im Gegensatz dazu übt die Sialylierung von 2B4 einen 
negativen Einfluss auf die Ligandenbindung aus, da die Interaktion zwischen 2B4 und 
CD48 nach Entfernung von Sialinsäuren erhöht wurde. Dieser Effekt konnte durch 
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funktionelle Tests bestätigt werden, da eine Desialylierung von NK Zellen oder die 
Inhibierung der O-Glykosylierung zur Verstärkung der 2B4-vermittelten Lyse von CD48 
exprimierenden Zielzellen führte.  
Diese Daten zeigen, dass die Glykosylierung von 2B4 einen wichtigen Einfluss auf die NK 
Zell Funktion besitzt. Veränderungen der Glykosylierung während NK Zell Entwicklung 
und Aktivierung könnten daher an der Regulation von NK Zell Antworten beteiligt sein. 
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1 INTRODUCTION 
1.1 Natural killer cells 
Natural killer (NK) cells were first discovered in 1975 as bearing the ability to lyse 
leukaemia cells in vitro without previous sensitization (Herberman et al., 1975a; 
Herberman et al., 1975b; Kiessling et al., 1975a; Kiessling et al., 1975b). On the basis of 
this experiment the term “natural cytotoxicity” was defined, although by now it is 
commonly known that NK cells are much more diverse in functionality. NK cells were first 
characterized as being CD56+CD3-, but recently it was recommended to use the marker 
NKp46 as being more specific over species barriers (Walzer et al., 2007a; Walzer et al., 
2007b). 
NK cells develop from the same progenitor as T and B cells and therefore represent the 
third lymphoid subpopulation (Colucci et al., 2003). Unlike T and B cells, NK cells do not 
exhibit somatic recombination but regulate their activity through germline encoded 
activating and inhibitory receptors. Because of their ability of being active without prior 
stimulation, NK cells belong to the first defense against viruses, pathogens and 
malignantly transformed cells. These characteristics led to the classification of NK cells to 
the innate immune system. NK cells comprise 5–15 % of circulating lymphocytes, but are 
also present in other tissues such as the gut, the lung and liver, as well as in the 
pregnant uterus, where they may have specialized functions (Tabiasco et al., 2006). The 
importance of NK cells became clear in patients born without or with impaired function of 
this lymphocyte subpopulation. These patients suffer from recurrent illnesses and have 
particular problems in controlling herpes viral infections despite their functional adaptive 
immune response (Biron et al., 1999; Janka, 2007; Nichols et al., 2005; Orange et al., 
2002). 
NK cell function can be divided into two parts: (1) Cytotoxicity, which can be performed 
in a perforin or a death receptor mediated manner. NK cells possess large numbers of 
preformed cytotoxic granules, containing perforin and various granzymes. Upon contact 
of NK cells with an appropriate target cell, granules are transported to the contact zone 
(also termed NK cell immunological synapse, NKIS) (Davis et al., 1999; Eriksson et al., 
1999b) where they are released into the synaptic cleft and lead to target cell apoptosis in 
a perforin and granzyme dependent manner. A more uncommon mechanism of target 
cell elimination by NK cells that also is slower in kinetic and less efficient, is the 
triggering of death receptors. Expression of tumor necrosis factor (TNF) related apoptosis 
inducing ligand (TRAIL) and Fas ligand (CD178) by effector NK cells triggers the 
appropriate death receptors on a target cell, leading to their apoptosis (Chavez-Galan et 
al., 2009). (2) The second function of NK cells is their ability to produce cytokines and 
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therefore to communicate with other cells of the innate and adaptive immune system. 
Important NK cell cytokines include interferon (IFN)-γ, tumor necrosis factor (TNF)-α as 
well as granulocyte-macrophage colony-stimulating factor (GM-CSF) (Biron et al., 1999). 
Especially IFN-γ and TNF-α are crucial for the T cell mediated protection against 
intracellular pathogens and cancer (Cooper et al., 2004; Moretta, 2002). NK cell helper 
function is also important for their crosstalk with dendritic cells (DCs), either by direct 
contact or by cytokine release (Degli-Esposti and Smyth, 2005).  
More than 48 distinct NK cell subsets have been defined, whose function and regulation 
are hardly known (Jonges et al., 2001). However, two distinct subsets of NK cells have 
been well characterized: CD56high CD16- cells are specialized in cytokine production 
whereas CD56dim CD16+ cells are the major cytotoxic NK cell subset (Colucci et al., 
2003). Recently, a new subset termed NK-22 has been identified which is essential for 
mucosal homeostasis. These NK cells bear the capacity to produce IL-22 and thereby 
contribute more to the homeostasis of the mucosal epithelia rather than to the classical 
NK cell functions like cytotoxicity and IFN-γ production (Cella et al., 2009; Malmberg and 
Ljunggren, 2009). 
 
1.2 Regulation of NK cell activity: “missing” and “induced” self 
In the early 1960s, it was a common hypothesis that transplanted tumor cells were 
rejected only when grafts express “foreign” MHC molecules which serve as antigens for a 
cytotoxic T cell response. 1964 Cudkowicz and Stimpfling found that F1-hybrid mice 
(derived from crossing of two inbred strains) were often resistant to tumor grafts of the 
parental origin (Cudkowicz and Stimpfling, 1964). This F1 hybrid resistance, which could 
not be correlated with a foreign antigen expression, was associated with NK cell activity 
soon after their discovery in 1975 (Kiessling et al., 1977). The F1 resistance led to the 
formation of the “missing-self” hypothesis (Karre, 2008; Karre et al., 1986). This model 
postulates that the absence or reduced expression of “self” MHC class I molecules leads 
to the recognition of and target cell lysis by NK cells. The theory was further supported 
by the identification of inhibitory NK cell receptors with specificity for self-MHC class I 
molecules (Karlhofer et al., 1992; Moretta et al., 1993). Target cells, which only had 
minor expression levels of MHC class I molecules, as often observed in tumors, virally 
infected cells or in the case of transplanted grafts, trigger the activation of NK cells due 
to their inability to deliver inhibitory signals (Ljunggren and Karre, 1990). 
For a long time, the theory of “missing-self” served as the only explanation of NK cell 
regulation. However, it became clear that the absence of inhibitory signals alone is not 
sufficient to induce target cell lysis. NK cells need to be triggered by activating receptors, 
too. This led to the model of the “induced-self” mechanism, whereby ligands lead to an 
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activation of NK cells despite the existence of an inhibitory signal (Watzl, 2003). We now 
know that the mechanism of NK cell regulation is much more complex, implying receptor 
expression as well as the balance and integration of signals delivered from activating and 
inhibitory receptors (see also Figure 1) (Lanier, 2005). 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 1: Illustration of missing and induced self. The NK cell (bottom) can bind via its 
activating and its inhibitory receptors to the attached target cell (top). The balance between the 
signals can shift to NK cell activation by the loss of inhibitory ligands (missing self) or by enhanced 
expression of activating ligands (induced self) on the target cell.  
 
1.3 Inhibitory receptors 
The first inhibitory NK cell receptors identified were the C-type lectin like Ly49 receptors 
in the mouse (Karlhofer et al., 1992). The human homologs are the killer cell 
immunoglobulin-like receptors (KIRs), which belong to the immunoglobulin (Ig)-
superfamily. The KIRs are type I transmembrane proteins and are divided into two 
groups based on their intracellular domain. Receptors with a long cytoplasmic domain (L) 
bear one or two immunoreceptor tyrosine-based inhibition motifs (ITIM) in their 
cytoplasmic tail and therefore act as inhibitory receptors. Short cytoplasmic forms (S) of 
KIRs lack this ITIM and instead associate with the immunoreceptor tyrosine-based 
activating motif (ITAM) bearing adaptor molecule DNAX activation protein (DAP)12 and 
function as activating receptors. Furthermore, both, activating and inhibitory KIRs 
contain two or three extracellular domains (D). Therefore, according to the number of 
extracellular domains and the length of the cytoplasmic tail, KIRs are classified as 
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KIR2D(S/L) or KIR3D(S/L). KIR receptors specifically recognize certain human leukocyte 
antigen (HLA)-A, -B or -C allotypes, but unlike T cells, not in a peptide specific way, 
although the peptide can contribute to KIR binding (Rajagopalan and Long, 1997, 2010). 
It has been shown that inhibitory KIRs exhibit a higher affinity to HLA molecules as their 
corresponding activating part, which may be a mechanism to avoid the risk of 
autoimmunity (Katz et al., 2001; Vales-Gomez et al., 1998).  
In addition to these Ig-like receptors, human NK cells express receptors of the C-type 
lectin-like family, namely NKG2, which form heterodimers with CD94 and some of them 
are inhibitory. The family comprises of NKG2A, -C, -E and -F. CD94/NKG2C heterodimers 
serve as activating receptors and transduce their signal via the adaptor molecule DAP12. 
NKG2A bears an ITIM in its cytoplasmic tail and therefore can deliver an inhibitory signal. 
The sequence of NKG2E is very similar to NKG2C and therefore it is assumed that it acts 
as an activating receptor, too, but up to now, an association with DAP12 couldn’t be 
shown (Lanier, 2005). Both, CD94/NKG2A and CD94/NKG2C complexes bind specifically 
to the non-classical MHC class I molecule HLA-E, which presents peptides derived from 
leader peptides of other MHC class I molecules. It is therefore a marker for the overall 
expression of MHC class I molecules. From this, the question arises, how NK cells decide 
which receptor - inhibitory or activating - is bound and stimulated. It has been shown 
that the inhibitory heterodimer comprising of CD94/NKG2A has a higher affinity for HLA-
E molecules than that consisting of CD94/NKG2C (Vales-Gomez et al., 1999). 
Furthermore, the peptides bound by HLA-E molecules may impair the binding affinity of 
CD94/NKG2C, too (Michaelsson et al., 2002). Hence, mechanisms to avoid autoimmunity 
may be a common feature of receptor families comprising of both, inhibitory and 
activating receptors, with similarity in their extracellular domains.  
An overview of the human inhibitory receptors is given in Figure 2. 
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Figure 2: Overview of the human inhibitory receptors and their ligands. Inhibitory KIRs and 
CD94/NKG2 complexes carry an ITIM in their cytoplasmic domain. KIRs are receptors of the Ig 
superfamily that bind to different HLA allotypes, while CD94/NKG2 receptors belong to the C type 
lectin like family and recognize HLA-E. 
 
1.4 Activating receptors 
The group of activating NK cell receptors is much more heterogeneous than that of 
inhibitory receptors. Beside the activating KIRs and CD94/NKG2 complexes, many 
activating receptors have been described, however, some of their ligands remain 
obscure.  
Among the activating receptors, the low affinity receptor for IgG, CD16 (FcγRIII) plays a 
special role. It transduces its signals via the ITAM containing accessory FcεRI-γ and CD3ζ 
chains and mediates antibody-dependent cellular cytotoxicity (ADCC). Therefore, it 
enables NK cells to recognize and eliminate pathogens or cells opsonized by antibodies 
by specific binding of the antibody’s Fc part to CD16. This mechanism is essential for 
antibody based therapies, like e.g. the treatment of B-cell non-Hodgkin lymphoma with 
rituximab (Anderson et al., 1997; Reff et al., 1994).  
Another important group for the activation of NK cells are the natural cytotoxicity 
receptors (NCRs) consisting of NKp30 (CD337), NKp44 (CD336) and NKp46 (CD335). 
Even though their cellular ligands are unknown, NKp44 and NKp46 are assumed to 
recognize viral hemagglutinin (Arnon et al., 2001; Mandelboim and Porgador, 2001). 
Apart from viral hemagglutinin, NKp30 has been shown to bind to human leukocyte 
antigen-B-associated transcript 3 (Bat3) (Pogge von Strandmann et al., 2007) and B7-
H6, a protein expressed specifically by tumor cells (Brandt et al., 2009). Because NCRs 
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lack intracellular signaling motifs on their own, they need to signal via adaptor molecules 
like CD3ζ (NKp30, NKp46), FcεRI-γ (NKp46) and DAP12 (NKp44) (Moretta et al., 2001). 
This is mediated by a positively charged amino acid residue in the transmembrane region 
of the NCRs that is pivotal for their interaction with ITAM bearing adaptor molecules.  
The C-type lectin NKp80 was recently characterized to be stimulated by activation-
induced C-type lectin (AICL, also CLEC2B), a myeloid-specific receptor expressed by 
monocytes, macrophages and granulocytes (Welte et al., 2006), but the signaling 
pathway remains to be resolved. DNAX accessory molecule 1 (DNAM)-1 binds the 
molecules poliovirus receptor (PVR) (CD155) and Nectin-2 (CD112) and also activates NK 
cells (Gilfillan et al., 2008). NKG2D belongs to the C-type lectin family, and recognizes 
MHC class I related chain (MIC) molecules A and B as well as UL-16 binding proteins 
(ULBPs). These ligands are upregulated during cellular stress and trigger the human 
homodimer NKG2D to signal via its adaptor molecule DAP10, whereas the murine 
receptor is also able to interact with DAP12 (Eagle and Trowsdale, 2007). 
The signaling lymphocyte activation molecule (SLAM) related receptors (SRRs) comprise 
another group of activating NK cell receptors. Because the (co)activating receptor 2B4 
(CD244) which belongs to this subfamily, is of special interest in this thesis, the SRRs will 
be described below. 
Figure 3 summarizes the activating NK cell receptors and their ligands. 
 
Figure 3: Overview of activating receptors and their ligands. Signaling motifs of the 
receptors or their respective adaptor chains are indicated. CD3ζ is symbolized by ζ and FcεRI-γ by 
γ. Human NKG2D interacts only with DAP10. 
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1.5 The SLAM family of immunoglobulin-like receptors 
1.5.1 SLAM-related receptors (SRR) 
The signaling lymphocyte activation molecule (SLAM) related receptors (SRRs) are a 
group of activating NK cell receptors consisting of six transmembrane proteins belonging 
to the Ig super family. This family comprises of SLAM (CD150), 2B4 (CD244), NK, T and 
B cell antigen (NTB-A), CD2-like receptor activating cytotoxic cells (CRACC, CS1) 
(CD319), CD84, and Ly-9 (CD229) (Bhat et al., 2006; Claus et al., 2008; Ma et al., 
2007; Veillette, 2006). The SRR family members are broadly expressed in the 
hematopoietic system. SRRs are expressed as type I transmembrane proteins with an 
amino-terminal V-type and a membrane proximal C2-type Ig-like domain. Ly-9 is an 
exception, as it comprises four Ig-like domains with an arrangement of V-C2-V-C2. With 
the exception of 2B4, SRRs interact homophilic. 2B4 interacts with CD48, a 
glycosylphosphatidylinositol- (GPI-) anchored molecule, broadly expressed on immune 
cells (Brown et al., 1998b; Latchman et al., 1998). In contrast to many other activating 
NK cell receptors described above, SRRs contain a distinct signaling motif, which differs 
also in its sequence from the common ITAM. SRRs contain different numbers of the so 
called immunoreceptor tyrosine-based switch motifs (ITSMs) and deliver their activating 
signal via SLAM-associated protein (SAP), Ewings sarcoma-Fli1-activated transcript 2 
(EAT-2) and EAT-2 related transcript (ERT, only in mice) (Latour and Veillette, 2004). 
These small molecules consist of a Src homology 2 (SH2) domain, with which they can 
bind to phosphorylated tyrosines of the ITSMs. The importance of SRRs and SAP became 
clear in patients suffering from X-linked lymphoproliferative disease (XLP), where the 
affected individuals carry a mutation in the gene encoding for SAP. In XLP, B and T cells 
as well as monocytes show a large expansion due to a dysregulated immune response 
initiated by Epstein-Barr virus (EBV) infection. In addition to transducing signals via 
activating molecules, SRRs are also able to associate with the phosphatases SHP-1/-2 
and SHIP, thereby transmitting inhibitory signals. The finding of binding signaling 
molecules with opposite effects led to the term switch motif (Bottino et al., 2001; 
Eissmann et al., 2005).  
Only 2B4, NTB-A and CRACC are expressed on NK cells. Whereas activating signals of 
2B4 and NTB-A depend on functional SAP as seen in XLP patients, CRACC seems to be 
independent of this adaptor molecule as CRACC signaling is not impaired in the disease 
(Bouchon et al., 2001). 
 
1.5.2 The 2B4 receptor (CD244) 
The SRR 2B4 is one of the best characterized surface receptors on NK cells, maybe due 
to the fact that it is expressed on all NK cells, rather than only on distinct subpopulations. 
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The identification of its ligand CD48 makes it possible to analyze the function of 2B4 due 
to possible stimulation with its natural ligand instead of antibody-mediated crosslinking.  
The receptor has first been described in murine lymphocytes with a non-MHC class I 
restricted NK cell like activity (Garni-Wagner et al., 1993). Rodents express two 
receptors with different length of their cytoplasmic domains due to different splicing 
variants (Mathew et al., 1993). The short form (2B4S) transduces an activating signal, 
whereas the long form (2B4L) exhibits inhibitory activity (Lee et al., 2004; Mooney et al., 
2004; Schatzle et al., 1999).  
Human 2B4 is a 365 amino acid type 1 transmembrane protein with a calculated 
molecular weight of 39 kDa and a pI of 9.16. It was first described in 1999 (Kubin et al., 
1999; Nakajima et al., 1999; Tangye et al., 1999). It has been reported that two 
isoforms of 2B4, h2B4-A and h2B4-B, could be expressed in human NK cells. These 
receptors differ by the addition of five amino acids between the distal IgV and the 
membrane proximal C2 domain of h2B4-B. This difference may impair the binding affinity 
for CD48 and therefore result in differential cytotoxic activity (Mathew et al., 2009), but 
this has to be confirmed in further studies. 
After engagement, human 2B4 induces cytotoxicity as well as cytokine production by 
triggering different signaling pathways (Chuang et al., 2001). In addition, 2B4 can also 
enhance signals induced by other NK receptors such as NKp30 and NKp46, thereby 
acting as a costimulator (Sivori et al., 2000). In this case, 2B4 crosslinking enhances 
receptor mediated signals to such an extent that in most cases a synergistical effect is 
observed. This means that the signal’s outcome is rather an amplification than the pure 
addition of both signals alone (Bryceson et al., 2006).  
In contrast to its activating feature, it has been shown that under certain circumstances 
2B4 may act as an inhibitory receptor. During development, activating receptors like 
NKp46 and NKp30 are expressed before HLA class I-specific inhibitory receptors. This 
critical state may impair the self-tolerance of NK cells. 2B4 was shown to prevent 
hyperresponsiveness by functioning as inhibitory receptor providing a fail-safe 
mechanism for NK cell development (Sivori et al., 2002). The inhibitory function of 2B4 
may be based on the absence of SAP as it has been reported to be responsible for the 
impaired immune response in XLP patients. However, the expression level of the receptor 
itself may also influence the balance between inhibition and activation of 2B4. It has 
been observed that a high receptor expression leads to an inhibitory, rather than to an 
activating response. Similarly, low expression of SAP or extensive antibody-mediated 
crosslinking induce inhibition. This dual role enables the immune system to adjust an 
adequate response by regulating a single receptor signaling pathway (Chlewicki et al., 
2008). 
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1.6 Signaling pathways  
Engagement of 2B4 by its ligand CD48 or antibody-mediated crosslinking leads to the 
recruitment of the receptor into so called “lipid rafts”, resulting in the phosphorylation of 
its ITSM domains by Src-family kinases (Watzl and Long, 2003; Watzl et al., 2000). Raft 
recruitment has been shown to be essential for phosphorylation of 2B4 (Watzl et al., 
2003). Upon phosphorylation, SAP associates with the ITSMs of 2B4, whereas the 
membrane proximal ITSM is essential for 2B4 signaling (Eissmann et al., 2005). EAT-2 
and in mice also ERT have been shown to be recruited to phosphorylated 2B4, too. All 
three adaptor molecules bear an SH2 domain which is sufficient for receptor binding. SAP 
also binds the Src kinase FynT (Chen et al., 2006) which leads to an increased receptor 
phosphorylation, whereas contrary findings for EAT-2 and ERT are discussed (Calpe et 
al., 2006; Clarkson et al., 2007; Roncagalli et al., 2005). The interaction of SAP with 
FynT occurs in an unusual SH2-SH3-domain dependent manner, involving the residue 
arginine-87 on SAP (Latour et al., 2003). While the phosphorylation of 2B4 occurs 
independently of SAP, the presence of SAP is crucial for signal transduction (Meinke, 
2010). A defect in SAP expression or a mutation on R87 impairs the 2B4 mediated 
signaling pathway completely and leads to the XLP disease. The association of EAT-2 with 
2B4 is still under investigation. Veillette and colleagues proposed an inhibitory outcome 
of the 2B4-EAT-2 association (Valiante and Trinchieri, 1993; Veillette et al., 2007) 
whereas in our hands EAT-2 binding to 2B4 is impaired in the absence of SAP (Meinke, 
2010). It is assumed that the affinity of EAT-2 to the ITSM of 2B4 is much lower than 
that of SAP and can be counteracted by EAT-2 overexpression or SAP mediated receptor 
recruitment. An additional adaptor molecule is 3BP2 which interacts with the fourth ITSM 
domain of 2B4 and whose phosphorylation leads to Vav signaling, ERK activation and NK 
cell cytotoxicity (Bottino et al., 2000).  
 
Figure 4: The model of 2B4 signal 
transduction. A Early signaling events in 2B4-
mediated lymphocyte activation B A possible 
mechanism for 2B4-mediated inhibitory signals 
in the absence of functional SAP, e.g. in XLP 
patients. Picture by courtesy of Claus et al., 
2008. 
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Inhibitory signals of 2B4 may occur due to binding of the phosphatases SHIP, SHP-1 and 
-2 to the third phosphorylated ITSM domain. Those phosphatases dephosphorylate other 
signaling molecules and thereby inhibit the receptor’s downstream signaling. 
Furthermore, the enzymes block the binding sites for SAP (Eissmann et al., 2005; 
Tangye et al., 1999). How the ITSM domain of 2B4 is phosphorylated remains unclear. 
Another mediator of inhibitory signals is Csk. This kinase was found to associate with 2B4 
and to phosphorylate its ITSM domain. Nevertheless, Csk inhibits Src-family kinases and 
thereby abolishes NK cell activation (Eissmann et al., 2005). 
Further studies with antibody mediated crosslinking of 2B4 molecules revealed the 
tyrosine phosphorylation of many substrates, including Vav1, SHIP-1, c-Cbl, 3BP2, p38 
MAPK, ERK1/2 and PLC-γ (Chen et al., 2004; Lanier, 2008; Watzl et al., 2000). However, 
results depend strongly on the experimental setup and cell type used. This also may 
contribute to the controversial results concerning SAP and EAT-2 mediated signaling 
described above.  
The phosphorylated ITIM of engaged inhibitory receptors bind the phosphatases SHIP, 
SHP-1 and -2, which in turn dephosphorylate several intracellular proteins (Tomasello et 
al., 2000; Watzl et al., 2000). Vav1 seems to be a key substrate for SHP-1. Thus, by 
controlling Vav1 phosphorylation, the decision of whether an activating signal proceeds 
downstream or not appears to be made. Vav1 phosphorylation therefore seems to be the 
first switch-like process in NK cells (Stebbins et al., 2003; Urlaub, 2009). The process of 
inhibition is spatially restricted to the inhibitory immunological synapse, also termed the 
supramolecular inhibition cluster - SMIC (Orange, 2008). Thus, the NK cell gains the 
possibility to still act on target cells lacking inhibitory ligands, whereas inhibition by 
further contacted cells is assured (Eriksson et al., 1999b).   
 
1.7 Membrane microdomains and their role in activation of NK cells 
Lipid rafts play an important role in the signal transduction of NK cells (Davis et al., 
1999; Fassett et al., 2001; Lou et al., 2000; Watzl et al., 2003). Lipid rafts are 
membrane microdomains enriched in cholesterol and glycosphingolipids, such as 
sphingomyelin and GM1, but contain also special proteins. In contrast to the surrounding 
lipid bilayer, rafts are highly ordered and tightly packed, due to the high concentration of 
more ordered lipid acyl chains. Additionally, cholesterol binds to sphingomyelin via 
hydrogen bonds and thereby leads to a tightly packed lipid layer, also known as the 
“condensing effect” (Lichtenberg et al., 2005).  
The concept of “lipid rafts” has often been linked with the terms liquid-ordered (lo) or 
detergent resistant membranes (DRM). However, recent studies provide differences 
between those terms (Lichtenberg et al., 2005). Liquid ordered phases are formed within 
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lipid bilayers as a result of local enrichment in sterols, e.g. cholesterol that hinders the 
formation of gauche conformations. The increased lipid acyl chain order forms a more 
compact state of lipids (Brown and London, 1997). Some of these lo phases are indeed 
detergent resistant, which means that they could prevent detergent incorporation into 
the lipid bilayer (Xu et al., 2001).  
So, what exactly are “lipid rafts”? These special membrane microdomains can be defined 
as organized membrane areas existing in vivo. Lipid rafts constitute lo-phase domains 
and may be partially separated from the surrounding plasma membrane by detergent. 
Consequently, by using the term “lipid raft”, the respective examination method has to 
be considered.  
Lipid rafts serve as signal platforms, as they separate membrane components from each 
other and thus create distinct areas with defined lipid and, of special interest, protein 
composition (Brown and London, 1998a). Among them are proteins with saturated acyl 
chains (including GPI-anchored proteins, myristoylated and palmitoylated proteins). 
These include important signaling proteins, such as Src-family kinases and heterotrimeric 
G protein alpha subunits (Hope and Pike, 1996; Simons and Ikonen, 1997; Zhang et al., 
1998) but also the GPI-linked CD48, the ligand of 2B4. Some integral membrane proteins 
extending through both lipid layers are also found in lipid rafts. Furthermore, 
constitutively and transiently raft associated proteins exist. Constitutive association 
seems to depend on S-palmitoylation (Dykstra et al., 2003) as has been shown for linker 
for activation of T cells (LAT) (Zhang et al., 1998) as well as the T cell coreceptors CD4 
and CD8 (Arcaro et al., 2000; Parolini et al., 1999). Despite this, some integral 
membrane proteins are normally excluded from lipid rafts and only translocate into the 
specialized membrane microdomain after ligation as e.g. the T cell receptor (TCR), B cell 
receptor (BCR), FcεR1 receptor and the NK cell activating receptors 2B4 and NKG2D 
(Dykstra et al., 2003; Endt et al., 2007; Masilamani et al., 2006; Simons and Toomre, 
2000; Watzl et al., 2003).  
These observations led to two models of raft-organization: In the first model, proteins 
are already localized in small lipid rafts, which are able to form stable and bigger 
complexes after receptor engagement (Lingwood and Simons, 2010; Pralle et al., 2000; 
Simons et al., 1997). The second model proposes only a small fraction of proteins to be 
constitutively localized in lipid rafts. Crosslinking of separated proteins induces clustering 
and thereby higher affinity for lipid rafts followed by recruitment of signal complexes into 
membrane microdomains (Brown et al., 1998a; Harder et al., 1998). It remains open, 
which of both models is correct or if both concepts may be right concerning particular 
membrane proteins.  
It has been demonstrated that the activating receptor 2B4 is recruited into DRMs upon 
engagement by crosslinking (Bottino et al., 2000) or by mixing NK cells with CD48 
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expressing target cells (Watzl et al., 2003). Thereby, the ITSM domains of 2B4 become 
phosphorylated by Src-kinases, which leads to NK cell activation (Bhat et al., 2006). Raft 
recruitment depends on phosphorylated Vav1, which induces the exchange from GDP to 
GTP of Rac1, which in turn leads to reorganization of the actin cytoskeleton. Blocking 
actin polymerization impairs the receptor recruitment as well as its phosphorylation, 
suggesting cytoskeletal rearrangement upstream of DRM recruitment and 
phosphorylation (Watzl et al., 2003). Cholesterol depletion, resulting in the disruption of 
lipid rafts, highlights the requirement of specialized membrane microdomains for 2B4 
functionality as it interferes with receptor phosphorylation and thereby completely blocks 
target cell lysis by NK cells (Hillyard et al., 2007; Watzl et al., 2003). 
NK cells bear the risk to be permanently stimulated due to constitutively expressed 
activating receptors and thereby leading to uncontrolled target cell lysis. At this point, 
inhibitory receptors come into play. DRM recruitment of 2B4 can be blocked by inhibitory 
KIR engagement, whereby the ITIM-bound SHP-1 seems to act upstream of 2B4 receptor 
phosphorylation (Watzl et al., 2003; Watzl et al., 2000). The same is true for the NKG2D 
receptor. Stimulation of this activating receptor results in its recruitment into DRM, 
whereas this can be blocked by engagement of the inhibitory CD94/NKG2A heterodimer 
(Endt et al., 2007).  
KIR inhibitory receptors are not found in lipid rafts, leading to the assumption that they 
interfere from outside with the formation of NKIS (Fassett et al., 2001). Nonetheless, the 
formation of an inhibitory synapse has been described as counterpart for the activating 
synapse leading to the discrimination between supramolecular activating cluster (SMAC) 
and supramolecular inhibitory cluster (SMIC). SMICs have been reported to be built after 
engagement of inhibitory KIRs, followed by their recruitment into the center of the 
contact area (Davis et al., 1999; Vyas et al., 2002). SMICs differ from the SMAC in that 
they exclude lipid raft components and do not accumulate actin filaments (Lou et al., 
2000; McCann et al., 2003). Instead, the phosphatase SHP-1 is recruited to SMICs, 
which can block the recruitment of activating receptors into lipid rafts (Vyas et al., 2004).  
The interplay between inhibitory KIR and activating receptors is summarized in Figure 5.  
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Figure 5: Crosstalk between activating and inhibitory signals. Upon triggering of activating 
receptors Vav1 gets phosphorylated and initiates a positive feedback loop of actin reorganization 
and recruitment of more activating receptors. Inhibitory receptors can block phosphorylation of 
Vav1 via the phosphatase SHP-1. 
 
1.8 Studying lipid rafts 
Most definitions and studies concerning lipid rafts are based on the method of cold non-
ionic detergent lysis and subsequent sucrose density gradient centrifugation. Therefore 
lipid rafts are defined as DRMs. However, this method has often been criticized to cause 
artifacts: (a) Classification of lipid raft marker proteins is dependent on detergent, 
temperature, and cell type and therefore varies with the experimental setup 
(Chamberlain, 2004; Schuck et al., 2003). (b) The use of detergent may also isolate 
molecules from intracellular membranes (Chamberlain, 2004). (c) The detergent may 
influence protein and lipid content due to rearrangement of intermolecular associations 
(Heerklotz, 2002). (d) It has been demonstrated that Triton X-100 enhances formation of 
lo domains or induces fusion of existing rafts (Simons and Vaz, 2004), thereby provoking 
false-positive conclusion. (e) Weak lipid-protein interactions may not be strong enough to 
resist detergent-mediated lysis (Schuck et al., 2003). (f) Cofractionation of two proteins 
in DRMs does not prove the colocalization of those proteins in the same rafts (van der 
Goot and Harder, 2001). Hence, non-invasive methods are needed to study the natural 
composition of lipid rafts. Several techniques have been used to shed light on membrane 
microdomains. Flow cytometry became a useful tool to study lipid rafts since the 
discovery that the subunit B of cholera toxin (CTXB) binds to GM1 with high affinity. 
However, it has to be considered, that CTXB induces small aggregates on ice, which 
became extensively larger after incubation at 37 °C (Hammond et al., 2005). Additionally 
to CTXB several fluorescently labeled lipid derivates exist, which can either mark the lo- 
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(raft) or ld- (non-raft) phase. Fluorophore-conjugated antibodies against cholesterol or 
other well-accepted raft-markers as GPI-anchored proteins like CD48, the ligand of 2B4, 
may be an option to localize membrane microdomains (Kiss et al., 2008). Imaging 
approaches using two-photon or confocal microscopy bear the advantage to visualize 
lipid domains in a nearly physiological manner, whereby optical approaches are limited 
by the resolution of the microscope used. Further non-invasive fluorescence-based 
methods with higher resolution are the often used Förster resonance energy transfer 
(FRET) microscopy (Rao and Mayor, 2005; Sharma et al., 2004), and the recently applied 
stimulated emission depletion (STED) far-field fluorescence nanoscopy (Eggeling et al., 
2009). Whereas the novel method of STED became attractive to study single molecules 
trafficking in nanosized areas, energy transfer methods are restricted to a pair of 
interacting proteins. Both techniques, as well as all visualization methods, are not 
applicable to the analysis of multimolecular complexes. A new method to study the 
composition of membrane microdomains was developed by Harder and Kuhn (Harder and 
Kuhn, 2001) based on the observation that TCR signaling complexes accumulate in the 
contact zone towards an anti-TCR coated magnetic bead (Hartgroves et al., 2003). 
Polarized cells were subsequently disrupted using nitrogen cavitation. Thereby, nitrogen 
is dissolved under high pressure into cells. Sudden release of pressure induces the 
nitrogen to become gaseous again. This is accompanied by an extension of the gas, 
which in turn results in stretching of the lipid membrane until the cell is ruptured. This 
mechanical approach bears several advantages: Firstly, the sample is rather chilled than 
warmed-up due to its adiabatic pressure release. Secondly, no detergent is used, 
preventing the mentioned lipid and protein disruptions. At least, the use of inert gas 
enables steady-state conditions without oxidation or changes in pH. By using this method 
of immunoisolation, protein as well as lipid composition surrounding the TCR signaling 
complexes have been successfully analyzed (Harder and Kuhn, 2000; Hartgroves et al., 
2003; Zech et al., 2009). 
 
 
1.9 Glycosylation of proteins 
Glycosylation is a diverse and highly regulated mechanism of posttranslational 
modification of proteins and lipids. Glycans are involved in many key biological processes 
including receptor activation, signal transduction, endocytosis as well as cell adhesion 
and molecular trafficking. In recent years, the knowledge about glycosylation and its 
function expanded enormously. Glycobiology became a popular field to understand 
structure, chemistry, biosynthesis, and biological function of glycans and their derivatives 
as well as their interrelation with other biological functions. The “glycome” is the 
complete quantity of sugars in an organism comparable with the term “proteome”. The 
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glycome differs highly between species and serves as self-nonself recognition mechanism 
among them, but also among organisms themselves. Indeed, pathogens are often 
recognized via their sugar moieties and faults in glycosylation cause developmental 
defects and severe diseases. The diversity of glycosidic modification makes identification 
and functional relation difficult and leads to the estimation that the variability of the 
human glycome exceeds that of the proteome. Especially the immense structure 
repertory and the multiplicity of linkages and combinations facilitate the linkage with 
each other and with different macromolecules and thereby increase the spectrum of 
complexity (Kottgen et al., 2003; Ohtsubo and Marth, 2006). The spectra of 
macromolecules is formed by diverse junctions of monosaccharides, mainly composed of 
D-glucose (Glc), D-galactose (Gal), D-mannose (Man), L-fucose (Fuc), D-xylose (Xyl), 
glucuronic acid and iduronic acid, as well as the amino sugars N-acetylglucosamine 
(GlcNAc), N-acetylgalactosamine (GalNAc) and the sialic acids (SA/Neu5Ac). However, 
despite the multiplicity of glycan structure, its synthesis is based on common cellular 
mechanism involving glycosyltransferases and glycosidases. 
Protein glycosylation includes N- and O-glycans as well as glucosaminoglycans 
(proteoglycans). In the following sections, the synthesis of N- and O-glycans as well as 
their involvement in cellular mechanisms will be described in detail. 
 
1.10 Structure and biosynthesis of N-glycans 
N-glycosidically bound carbohydrates are linked via N-acetlyglucosamine to the 
asparagines residues within the N-!P-[S/T] sequence motif (where !P is any amino acid 
except proline). However, Zielinska et al. have shown that N-glycosylation is not 
restricted to this consensus sequence or the uncommon N-X-C motif but can also be 
found on yet unknown positions (Zielinska et al., 2010). Furthermore, only 30 % of all 
available motifs within a protein are glycosylated with some of them showing only 
incomplete glycosylation (Mellquist et al., 1998).  
The biosynthesis of N-glycans starts in the cytosolic compartment of the rough ER (rER) 
(for details see also Figure 6). Herewith, an oligosaccharide precursor is formed by the 
transfer of GlcNAc from UDP-GlcNAc to dolichol phosphate (Dol-P). This step can be 
inhibited by tunicamycin. This mixture of homologous nucleoside antibiotics inhibits the 
GlcNAc phosphotransferase (GPT) to catalyze the initial step of N-glycosylation. The rest 
of the sugar core is added subsequently till the Dol-P-P-(GlcNAc)2-(Man)5 tree is 
completed. The oligosaccharide “flips” into the lumen of the rER, where it is completed by 
the addition of 4 Man and 3 Glc residues. 
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Figure 6: Process of N-glycosylation. UDP-GalNAc is transferred to Dol-P (oval) in the 
cytoplasm at the rough ER (light gray) membrane. After addition of GlcNAc and 5 Man to the 
growing sugar tree, the structure “flips” (dashed line) to the inside of the rER, where further sugar 
moieties are added and the tree subsequently is transferred to a peptide‘s Asn residue (box). After 
several Man and Glc residues have been removed, the peptide is transferred (dotted line) to the 
Golgi (dark gray), where further Man residues are removed and GlcNAc and Gal are added. 
Addition of the GlcNAc marks conversion to the complex type. The resulting branched N-glycan 
structure can be further elongated by the sequential addition of Gal, Fuc and SA. An exemplified 
tree is shown. For abbreviations see text. Inhibitors are included. 
 
The assembled precursor molecule is subsequently transferred by oligosaccharyl-
transferase cotranslationally to the nascent polypeptide. This step can also be inhibited 
by tunicamycin as well as amphomycin. Two glycosidases (α1,2-glucosidase I, α1,3-
glucosidase II) remove the terminal Glc residues. Both enzymes can be inhibited by 
further chemicals, as well. After additional removal of one Man residue by α1,2-
mannosidase the glycosidic tree is transported from the rER to the Golgi compartment. 
This transport is receptor mediated and can be inhibited by Brefeldin A (Kleene and 
Schachner, 2004; Moremen et al., 1994). Here, the glycosidic tree is terminated 
depending on its final destination, which is determined by the amino acid sequence of the 
protein. The processing mostly begins with the ablation of further mannose residues and 
stepwise addition of GlcNAc, Gal and finally Neu5Ac. This leads to the formation of 
different “antennae”. The transfer of sialic acid residues terminates the glycosidic tree, as 
they cannot serve as target for glycosyltransferases or glycosidases, generally. The 
trimming and processing mechanisms in the Golgi compartment is highly complex and 
ends in different oligosaccharide structures: high mannose types, ending with 
unsubstituted Man residues, hybrid types and complex types. The latter are mostly 
secreted or cell surface N-glycans.  
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Despite their large modification variability, N-glycans possess a common core structure, 
resulting from the transfer of the oligosaccharide precursor (Beyer et al., 1979; Kleene et 
al., 2004; Kornfeld and Kornfeld, 1985). Even though many of the mutations affecting N-
glycosylations are lethal (Freeze and Westphal, 2001), in recent years, it has become 
evident that defects in the attachment of carbohydrates to proteins are implicated in a 
number of human diseases. Among these, the congenital disorders of glycosylation 
(CDGs) refer to a large number of syndromes that include severe morphogenic and 
metabolic defects. Molecular causes for some of the syndromes included have been well 
investigated. The most prevalent ones are due to a mutation in the PMM2 gene. These 
mutations diminish the production of the dolichol-oligosaccharide precursor, which is 
essential for the initiation of N-glycosylation (Ohtsubo et al., 2006; Spiro, 2002). 
Furthermore, N-glycans have been shown to be involved in modulating the conformation 
and activity of integrins and extracellular matrix (ECM) proteins (Janik et al., 2010). 
Thus, improper glycosylation of cell surface proteins involved in cell adhesion as e.g. 
integrins, can result in different adhesion behavior. This in turn has been shown to lead 
to enhanced metastatic potential of tumor cells (Zhao et al., 2008).  
Proper N-linked glycosylation therefore is a tightly regulated and controlled process that 
determines the fate of molecules and whole organisms (Ohtsubo et al., 2006). 
 
1.11 Structure and biosynthesis of O-glycans 
In contrast to N-linked glycans, the synthesis of O-linked glycans is less well established. 
The main types of O-linked glycans are those of the mucin and the proteoglycan type. 
Both are generated relatively late during protein processing in the Golgi compartment 
(Ungar, 2009). Mucin type O-glycans are attached to serine or threonine residues and at 
later stages during protein processing. However, a consensus sequence has not been 
elucidated, so far. GalNAc represents the first sugar to be linked to serine or threonine. It 
is transferred from UDP-GalNAc to the hydroxyl group of Ser or Thr by a large family of 
up to 20 different GalNAc transferases in cis Golgi compartments (Tarp and Clausen, 
2008). The chemical compound Benzyl-α-N-GalNAc (BADG) competes with endogenous 
galactosyltransfer and thus inhibits the proceeding of O-linked glycosylation (Kuan et al., 
1989). Starting from the first GalNac, there are several different possibilities to further 
elongate the O-linked glycan in trans Golgi vesicles by different glycosyltransferases, 
depending on the linkage and the sugars used (details for the synthesis are shown in 
Figure 7) (Tarp et al., 2008). There are four different starting structures (core1-4) and 
they are often elongated by the addition of further Gal, GlcNAc or GalNAc residues and 
usually are terminated by Fuc, Neu5Ac, or both (Dall'olio, 1996). Modifications and 
mutations in O-glycosylation were shown to potentially promote tumor cell growth and 
survival by influencing cell adhesion (Hollingsworth and Swanson, 2004) by impairing 
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e.g. the cytotoxicity of NK cells (Ogata et al., 1992) or of T lymphocytes (van de Wiel-
van Kemenade et al., 1993). 
 
Figure 7: Synthesis of mucin type O-glcans. Mucin type glycans are attached to serine or 
threonine. GalNAc represents the first sugar to be linked to Ser or Thr of a polypeptide (boxed). It 
is transferred from UDP-GalNAc to the hydroxyl group of Ser or Thr by a large family of up to 20 
different GalNAc transferases in cis Golgi compartments (Tarp et al., 2008). Starting from this 
GalNac, there are several different possibilities to further elongate the O-linked glycan in trans 
Golgi vesicles by different glycosyltransferases. If Gal is linked via β1,3 linking to the O-3 position 
the so called core 1 structure is formed, which is the basis for most of the mucin-type O-linked 
glycans. In mammals, this reaction is carried out by a single core1 Gal transferase. Further 
attachment of GlcNAc via β1,6 linking to the initial GalNAc by one of three GalNAc transferases 
results in the core2 structure (Tarp et al., 2008). In contrast β1,3 linking of GlcNAc to the initial 
GalNAc leads to the core3 structure. Core3 may serve as substrate for an enzyme catalyzing the 
core 4 reaction. Here, GlcNAc is added in a β1,6 linkage to GalNAc similar to synthesis of the core 2 
structure (Tarp et al., 2008). These four starting structures often are elongated by the addition of 
further Gal, GlcNAc or GalNAc residues and usually are terminated by Fuc, Neu5Ac, or both. BADG 
competes for sugar elongation, where indicated. For abbreviations see text. 
 
1.12 Sialic acids (SA) 
Sialic acids are derivates of neuraminic acid. The monosaccharides with a nine-carbon 
backbone contain a carboxylgroup, which leads to the addition of one negative charge at 
physiological pH. Diversity of sialic acids is generated by different substitutions based on 
the neuraminic acid moiety. About 50 sialic acid types are known. The most frequent 
synthesized forms are N-acetylneuraminic acid (Neu5Ac), followed by N-
glycolylneuraminic acid (Neu5Gc) and O-acetylated derivatives, mostly N-acetyl-9-O-
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acetylneuraminic acid (Neu5,9Ac2) (Varki and Schauer, 2009). Sialic acids are mainly 
found at the end of glycoproteins and glycosphingolipids. In N-glycans, sialic acids are 
mainly linked α2,3 or α2,6 to Gal, in O-glycans they are usually linked to GalNAc (Blix et 
al., 1956). A special sialylation moiety is found on the neuronal cell adhesion molecule 
NCAM (CD56). Herewith, a large glycopolymer consisting of α2,8 linked sialic acids is 
found, which can reach up to 100 sugar residues (Finne et al., 1983). Due to their 
terminal position and negative charge, sialic acids exhibit the ability to interact with other 
molecules and thereby serve as recognition site, but also may inhibit intermolecular and 
therefore intercellular interaction (Schauer, 2009). 
The influenza virus from birds and pigs is able to recognize and bind α2,3 linked sialic 
acids via its hemagglutinin. The viral Neuraminidase is important for viral release, as it 
cleaves the carbohydrate bond and therefore enables the viral core to bud from the cell 
surface. In contrast, human influenza virus mainly recognizes α2,6 linkages. Hence, a 
mutation in the hemagglutinin gene could enable the avian virus to infect human cells, 
leading to a pandemic effect. 
It has recently been shown that sialylation has an important role during the maturation 
from double positive to CD8 single positive cells: Immature CD8+ T cells sustain a low 
level of sialylation whereas naïve T cells are highly sialylated. This core1-O-linked 
sialylation plays an important role, as it decreases the cognate binding of CD8 towards 
MHC class I molecules. Another example that glycosylation, in particular sialylation, plays 
a major role in regulating lymphocyte activity is the complex mechanism of CD22 
signaling (also known as Siglec-2). It modulates BCR signaling by inhibiting its 
downstream events and thereby preventing a constant activation of B cells. It became 
clear that CD22 interacts with α2,6 sialic acid residues of IgM, the main part of the BCR, 
on the same surface. This cis interaction leads to tyrosine phosphorylation of CD22 and 
finally to BCR signal inhibition (Jin et al., 2002; Kelm et al., 2002). However, trans 
interaction of CD22 with its ligand is able to control the BCR activation strength. Maybe 
CD22 moves in concert with IgM into the contact zone, where its engagement results in a 
direct down-modulation of the BCR (Lanoue et al., 2002). As α2,6 sialic acids are 
ubiquitously synthesized by human cells, the CD22 trans interaction could be a 
mechanism to avoid autoimmunity.  
 
1.13 Glycan binding proteins - Siglecs 
Carbohydrates seem to be rather involved in fine tuning, or act as molecular switches 
(Schauer, 2009), as the affinity of proteins for carbohydrates is relatively low (Kd valued 
in micromolar to low millimolar range). However, the specificity is relatively high. 
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Furthermore, the avidity of glycan-binding proteins is enormous, as some of them can 
bind multiple glycan moieties.  
Lectins are a group of glycan binding proteins first identified in plants. Lectins can be 
devided into 5 groups (R-, L-, C-, P- and I-type,) due to their ligand recognition 
characteristics. Siglecs (sialic acid binding Ig-like lectins) belong to the I-type lectins as 
they recognize carbohydrates via an Ig-domain. They are mostly expressed on 
hematopoietic cells and contain a cytoplasmic ITIM domain, thereby transmitting 
inhibitory signals (Sperandio et al., 2009). NK cells express Siglec-7 and -9, which are 
able to suppress NK cell activation (Yamaji et al., 2005). Recently, it has been shown 
that the mucin MUC16, which is highly expressed by epithelial ovarian cancers, is 
recognized by Siglec-9 in a sialic acid dependent manner (Belisle et al., 2010). This 
interaction is thought to suppress NK cell activity and thereby dampen an anti-tumor 
response.  
 
 
In summary, glycans are involved in many cellular and also metastatic processes and 
represent an enormous role in altering protein-protein or protein-carbohydrate 
recognition. Protein glycosylation is highly ordered and regulated and defects in 
glycosylation are lethal or results in severe diseases. Sometimes, glycans are the only 
variation between otherwise identical glycoproteins. These differences can occur within 
one and the same cell, resulting in a “microheterogeneity” (Ohtsubo et al., 2006), which 
does not necessarily abolish or induce recognition, but may modify the interaction with 
other molecules. Determining the regulation of glycosylation, their alterations and 
outcome in cell-cell communication will provide profound insights into the role of glycans 
in mammalian diseases and immunity.  
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2 AIMS OF THE THESIS 
NK cells represent a tool for the immune system to act against malignant and virus 
infected cells. It is therefore important to understand the early signaling events after the 
triggering of activating NK cell receptors and the mechanisms regulating receptor affinity.  
In a first approach a bead-based isolation method to analyze membrane microdomains 
surrounding NK cell receptors and its adjacent cytoplasmic parts should be established. 
As mentioned before, many observations aimed at the use of detergents to characterize 
regions of mostly activating immune cell receptors. However, the use of detergents is 
discussed controversial to result in artifacts due to artificial membrane disruption. 
Furthermore, the commonly used methods fail to authentically depict the in vivo situation 
and does not allow for analysis comparing activating and inhibitory receptor signaling. To 
analyze a more natural composition of membrane microdomains surrounding NK cell 
receptors, the antibody coated bead based system developed by Harder and Kuhn 
(Harder et al., 2001) should be modified to study the outcome of NK cell stimulation. 
This method would also enable us to investigate inhibitory NK cell receptors, as those are 
not recruited into DRMs and thereby fail to be examined by chemical disruption methods. 
After successful establishment, the system should be used to investigate time-dependent 
changes of adjacent proteins, as well as differences between activating and inhibitory 
receptors with respect to associated molecules. 
The second aim was to investigate posttranslational modifications of 2B4 and their 
outcome in NK cell activation. 2B4 represents a highly glycosylated protein with several 
proposed N-glycosylation sites (Tangye et al., 1999 and this thesis). However, up to 
now, the influence of 2B4 associated glycans remains elusive. Since glycans can have 
multiple implications for ligand recognition and functional outcome, we proposed 
influences of 2B4 associated glycans as well. Characterization of glycosidic alterations of 
2B4 expressed by different NK cell lines and also primary NK cells as well as their 
modification should give us information about the carbohydrate composition and their 
influence in receptor affinity. By using glycosylation inhibitors, we aim to test how 
glycosylation may impair 2B4 mediated target cell killing. 
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3 MATERIAL AND METHODS 
3.1 Materials 
3.1.1 Mouse monoclonal antibodies 
Name Conjugate Source, Reference 
IgG control, MOPC21 none, PE Sigma, Taufkirchen, Germany 
anti-2B4 (C1.7) none, PE Immunotech, Marseille, France 
anti-NKG2D (149810) none, PE RnD Systems, Minneapolis, USA 
anti-NKp30 (p30-15) none, PE (Hoffmann et al., 2007) + BioLegend, 
Uithoorn, The Netherlands 
anti-NKG2A/CD159a (Z199) none Beckman Coulter, Fullerton, USA 
anti-CD45 none BD Pharmingen, Germany 
anti-CD48 (MEM-102) none, PE Santa Cruz Biotechnology, Germany + 
BD Pharmingen, Germany 
anti-Vav1 (VAV-30) none Abcam, Cambridge,  USA 
anti-phospho-tyrosine, 4G10 biotin Upstate cell signaling solutions, 
Charlottesville, VA, USA 
anti-ILZ none Stark et al., 2005 
 
3.1.2 Rabbit polyclonal antibodies 
Name Source, Reference 
anti-2B4 Watzl et al., 2000  
anti-phospho Vav1 pY160 Biosource, Camarillo, CA 
 
3.1.3 Secondary antibodies 
Name Conjugate Source, Reference 
goat-anti-mouse IgG none Dianova, Hamburg, Germany 
goat-anti-mouse IgG HRPO Jackson ImmunoResearch 
Laboratories, USA 
goat-anti-mouse IgG PE Jackson ImmunoResearch 
Laboratories, USA 
goat-anti-rabbit IgG HRPO Santa Cruz Biotechnology, Heidelberg, 
Germany 
goat-anti-human IgG Biotin Jackson ImmunoResearch 
Laboratories, USA 
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3.1.4 Recombinant proteins 
Name Tag Source 
2B4-ILZ ILZ followed by 
6xHis (C-terminal) 
Stark et al., 2005 and this thesis 
rhSiglec7-Fc Chimera Fc RnD Systems, Minneapolis, USA 
 
3.1.5 Cells 
All culture media, fetal calf serum (FCS), non-essential amino acids and sodium pyruvate 
were purchased from Gibco (Invitrogen, Carlsbad, CA); donor horse serum was 
purchased from Biochrom (Berlin, Germany), human serum from PromoCell (Heidelberg, 
Germany), PHA-P from Sigma and purified human IL-2 from Hemagen Diagnostics 
(Columbia, USA). If not indicated otherwise, all cells were grown with 10 % (v/v) FCS 
and 1 % (v/v) penicillin/streptomycin (Gibco, Invitrogen). 
Cell type Origin Culture Medium 
NKL human NK cell line RPMI, 100 U/ml IL-2 
NK92C1 human NK cell line from malignant 
non-Hodgkin lymphoma 
Alpha MEM, 12.5 % (v/v) 
FCS, 12.5 % (v/v) donor 
horse serum, 2-
mercaptoethanol 
primary human 
NK cells 
isolated from peripheral blood 
mononuclear cells (PBMC) by 
negative selection 
IMDM, 10 % (v/v) human 
serum, 10 % (v/v) non-
essential amino acids, 10 % 
(v/v) sodium pyruvate, 
100 IU/ml IL-2 
HeLa cervical cancer cell line DMEM 
HEK-293T (HEK) human embryonic kidney cell line DMEM 
HEK-2B4 HEK-293T cells, stably transfected 
with human 2B4 
DMEM + 1 µg/ml puromycin 
HEK-CD48 HEK-293T cells, stably transfected 
with human CD48 
DMEM + 1 µg/ml puromycin 
HeLa-CD48 cervical cancer cell line, stably 
transfected with human CD48 
DMEM + 1 µg/ml puromycin 
HeLa-Mock cervical cancer cell line, stably 
transfected with human CLEC12B 
DMEMµ + 1 µg/ml puromycin 
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3.1.6 Enzymes 
Name Use Source 
CIP (Calf Intestinal 
Phosphatase) 
depohosphorylation of 
proteins 
New England Biolabs, 
Frankfurt, Germany 
PNGaseF (Peptide-N-
Glycosidase F) 
de-N-glycosylation of 
proteins 
Sigma, Germany 
Neuraminidase (Arthrobacter 
ureafaciens α2-3,6,8,9-
Neuraminidase) 
desialylation of proteins and 
cells 
Merck-Calbiochem, 
Darmstad 
O-Glycosidase (Endo-α-N-
Acetyl galactosaminidase) 
de-O-glycosylation of 
proteins 
New England Biolabs, 
Frankfurt 
 
3.1.7 Inhibitors 
Name Use Source 
BADG (Benzyl-2-acetoamido-2-
deoxy-α-D-galactopyranoside; 
dissolved in DMSO) 
inhibitor for O-glycosylation Merck, Calbiochem 
TM (tunicamycin) inhibitor for N-glycosylation Merck, Calbiochem 
 
3.1.8 Plasmids 
Name Comment Source 
2B4-ILZ expression construct for 2B4-
ILZ fusion protein 
Stark et al 2005 
dIgC2 (2B4-deltaIgC2) expression construct for 
human 2B4, deleted of the 
membrane proximal C2 type 
Ig domain 
Claus et al, 
unpublished results 
Y1,2,3,4F (2B4-Y1,2,3,4F) expression construct for 
human 2B4 with all ITSM 
tyrosins mutated to 
phenylalanine 
Eissmann et al., 
2005 
 
3.1.9 Kits 
Isolation of human NK cells NK Cell Negative Isolation Kit, Invitrogen (formerly 
Dynal, Oslo, Norway) 
Quantification of protein 
concentration 
EZQ Protein Quantitation Kit, Molecular Probes, 
Invitrogen 
Quantification of surface 
molecules 
Qifikit, Dako 
IFN-γ measurement Human IFN-γ ELISA, Bender Med Systems, Vienna 
Silverstaining SilverSNAP Silver Stain Kit II, Thermo Scientific 
CyDye DIGE Fluor minimal dye 
labeling kit 
GE-Healthcare, Freiburg, Germany 
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3.1.10 Buffers 
 
Triton X-100 lysis buffer:  150 mM NaCl 
 20 mM Tris-HCl, pH 7.4 
 10 % (v/v) Glycerol 
 0.5 % (v/v) Triton X-100 
 2 mM EDTA 
 10 mM NaF 
 1 mM PMSF 
 1 mM Na-orthovanadate (for studies on 
protein phosphorylation) 
 
 
PBS (pH 7.4): 137 mM NaCl 
 8.1 mM Na2HPO4 
 2.7 mM KCl 
 1.5 mM KH2PO4 
 
PBST: 1 x  PBS 
 0.05 % (v/v) Tween 20 
 
PBST/NaCl: 1 x  PBS 
 0.05 % (v/v) Tween 20 
 0.5 M NaCl 
 
1 x  PBST Blocking buffer for Western blot: 
5 % (w/v) nonfat dry milk powder, Saliter, 
Obergünzburg 
 
PBS/pervanadate: 1 x  PBS 
 10 mM  H2O2 
 200 µM Na-orthovanadate 
 
Western blot transfer buffer: 24 mM Tris 
 129 mM Glycin 
 20 % (v/v) MeOH 
 
5xRSB (reducing sample buffer): 10 % (w/v) SDS 
(for 1x and 2x RSB, dilute with 50 % (v/v) Glycerol 
50 % Glycerol) 25 % (v/v) 2-Mercaptoethanol 
 0.1 % (w/v) Bromphenol Blue 
 0.3125 mM Tris-HCl, pH = 6.8 
 
200 mM Glycin Stripping buffer (pH 2.2) for 
Western blot: 0.1 % (w/v) SDS 
 1 % (v/v) Tween 20 
 
MATERIALS AND METHODS 
 
37 
 
Immunoisolation: 
IMDM Hepes + FCS: 1x IMDM 
 1 % (v/v) Hepes 
 50 mM FCS 
 
1000xCLAP (protease inhibitor, 
dissolved in DMSO): 10 mg/ml Chymostatin  
 10 mg/ml Leupeptin 
 10 mg/ml Antipain 
 10 mg/ml Pepstatin 
  (all Sigma, Germany) 
 
100xDNAse: 50 % (v/v) Glycerol 
 150 mM NaCl 
 10 mg/ml  DNase (≥2,000 Kunitz units/mg) 
(Sigma, Germany) 
 
HB (HBuffer): 250 mM  Sucrose 
 10 mM  Na-Hepes pH 7.2 
 10 mM  NaF 
 50 mM  NaCl 
 1 mM  Na-orthovanadate 
 
HB+ (HBuffer+): 1x HB 
 1x CLAP 
 1x DNase 
 prepare immediately before use 
   
 
2D-Gelelectrophoresis: 
CHAPS/ASB-14 lysis buffer 7 M  Urea 
 1 M Tris-Base 
 2 M Thiourea 
 4 % (w/v) detergent (ASB-14 or CHAPS) 
 
CHAPS/ASB-14 2xSB (sample 
buffer) stock solution  7 M  Urea 
 2 M Thiourea 
 2 % (w/v) detergent (ASB-14 or CHAPS) 
 
Rehydration Solution         (2,5 ml) 2x SB stock 
 2 % (50 µl) IPG Buffer, pH 3-10 or pH 3-11 
(BioRad) 
 2 % (50 mg) DTT 
 
DeStreak Rehydration Solution 
(for 2D-DIGE)        (3 ml) 
DeStreak Rehydration Solution 
(GE Healthcare) 
 2 % (60 µl) IPG Buffer, pH 3-11 (BioRad) 
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SDS equilibration buffer pH 7.0: 75 mM Tris, pH 8.8 
 6 M  Urea 
 30 % (v/v) Glycerol 
 2 % (w/v)  SDS 
 
Equilibration buffer I: SDS equilibration buffer incl. 0.5 % (w/v) DTT 
 
Equilibration buffer II: SDS equilibration buffer incl. 4.5 % (w/v) 
Iodacetamid 
 
10xSDS electrophoresis running 
buffer pH 8.3 
250 mM Tris-HCl 
 19.2 mM Glycine 
 1 % (w/v) SDS 
 
Fixation solution 50 % (v/v) Methanol 
 7 % (v/v) Acetic acid 
 
Washing solution 10 % Methanol 
 7 % Acetic acid 
 
 
Protein purification: 
HBS (2x)(pH 7.0): 13 g/l (w/v)  Hepes 
 16 g/l (w/v) NaCl 
 3 mM Na2HPO4 
 
ILZ wash buffer (pH 8.0): 50 mM  NaH2PO4 
 300 mM NaCl 
 20 mM Imidazole 
 0.05 % (v/v) Tween 20 
 
ILZ elution buffer (pH 8.0): 50 mM  NaH2PO4 
 300 mM NaCl 
 250 mM Imidazole 
 0.05 % (v/v) Tween 20 
 
 
MOPS buffer (20 x) (Invitrogen)  
TAE (10 x) (Invitrogen)  
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3.1.11 Chemicals and reagents 
Most chemicals were purchased from Roth (Karlsruhe, Germany), Sigma-Aldrich (Seelze, 
Germany), Merck (Darmstadt, Germany). 
Name Source 
BSA Serva, Heidelberg, Germany 
Chromium-51 Hartmann Analytik, Braunschweig 
Dynabeads: Protein G, Pan mouse 
IgG, goat-anti-mouse 
Dynal, Invitrogen 
recombinant human IL-2 NIH cytokine repository 
recombinant human IL-15 R&D Systems, Minneapolis, USA 
IPG buffer / ampholytes Bio-Rad 
ReadyStrip IPG pH3-10 (7 cm) Bio-Rad 
Immobiline Dry Strip pH3-11 NL 
(24 cm) 
GE-Healthcare, Freiburg, Germany 
LSM solution PAA, Pasching, Germany 
Ni2+-NTA Agarose  Qiagen, Hilden, Germany 
Phosphatebuffer G7-Reactionbuffer NEB Biolabs 
PVDF Blot membrane Millipore 
Puromycin Sigma, Germany 
Precision Plus Protein Standard BioRad, Hercules, CA 
Protein G agarose Invitrogen  
NuPAGE Gels Invitrogen 
Streptavidin-HRPO Jackson ImmunoResearch Laboratories, USA 
Streptavidin-PE Jackson ImmunoResearch Laboratories, USA 
SuperSignal West Pico and Dura Thermo 
SYPRO Ruby Protein Gel Stain Molecular Probes, Invitrogen 
TrypLE Express Invitrogen 
X-ray films Perbio/Pierce, Rockford, IL 
 
3.2 Methods 
3.2.1 Cell culture  
All cells were grown at 37 °C and 5 % CO2 in a humidified incubator under sterile 
conditions. Cell lines were splitted on a regular basis every two to three days. Cell culture 
flasks were exchanged every week. Cells were frozen in FCS containing 10 % DMSO at 
-75 °C and stored in liquid nitrogen. Cell lines were thawed on a regular basis. FCS and 
human serum were heat inactivated by incubation on 56 °C for 30’ prior to use.  
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3.2.2 NK cell isolation  
Human polyclonal NK cells were isolated from whole blood or buffy coats. First peripheral 
blood mononuclear cells (PBMC) were purified by density centrifugation over LSM 
solution. Then NK cells were isolated using the NK cell negative isolation kit from Dynal 
(Invitrogen). NK cells were between 90 % and 99 % NKp46+, CD3- and CD56+. After 
isolation, NK cells were plated on 96 well round bottom plates at 1x106-2x106 cells/ml 
with 5x105 cells/ml irradiated JY cells. Growing cells were expanded 1:1 with IMDM 
medium supplemented as described above. 
 
3.2.3 Cell stimulation  
3.2.3.1 Cell stimulation with beads 
Dynabeads were washed three times with IMDM Hepes+FCS medium and resuspended in 
the initial volume or at least 50 µl. Human-anti-mouse coupled Dynabeads comprise of  
4x108 beads/ml. 2 µg of mouse antibody was added per 107 beads and incubated for 1 h 
at room temperature at a rotating wheel. After three washes, the Dynabeads were 
resuspended at 4x108 beads/ml in medium. Cells were harvested, washed three times 
and prepared as cell pellet in a 1.5 ml Eppendorf microcentrifuge or 15 ml Falcon tube. 
Antibody-coated Dynabeads were added at a ratio of 1:2 to the loosened cells, mixed 
carefully and incubated 5’-10’ on ice. Cell-bead conjugates were transferred to 37 °C or 
to 4 °C for the desired time and reaction was stopped by adding 1-5 ml ice-cold HB and 
incubation for 5’ on ice. Cell-bead conjugates were pelleted by centrifugation for 2’ at 
500xg at 4 °C.  
 
3.2.3.2 Pervanadate stimulation 
Protein phosphorylation was induced by using the phosphatase inhibitor pervanadate. 
Cells were resuspended at 2x107 cells/ml in PBS/pervanadate solution and incubated for 
10’ at 37 °C. 
 
3.2.4 Quantification of cell-bead contacts 
Cell-bead conjugates were performed as described in 3.2.3.1. Cells and beads were 
counted using a conventional hemocytometer in four 1 mm2 chambers, respectively. 
Contacts per bead were calculated as (contacts between cells and beads)/(total bead 
number) and contacts per cell were calculated as (contacts between cells and 
beads)/(total cell number). 
 
MATERIALS AND METHODS 
 
41 
 
3.2.5 Chromium-release assay 
Cell lines were grown to mid log phase, primary NK clones were used at 3-4 weeks of 
age. Usually, 1x105 NKL, 5x104 NK92C1 or 2,5x104 primary NK cells per well were used 
at highest effector:target ratio. 5x105 HeLa-CD48 or HeLa-Mock target cells were labeled 
in 100 µl medium with 100 µCi 51Cr (3,7 MBq) for 1 h at 37 °C. Cells were washed twice 
in medium and resuspended at 5x104 cells/ml in medium. 5000 target cells/well were 
used in all assays. Maximum release was determined by incubation of target cells in 1 % 
Triton X-100. For spontaneous release, targets were incubated without NK cells in 
medium alone. All samples were done in triplicates. Plates were incubated for 4 h at 
37 °C, 5 % CO2. Supernatant was harvested and 51Cr release was measured in a gamma 
counter. Percent specific release was calculated as ((experimental release - spontaneous 
release) / (maximum release - spontaneous release)) x 100.  
 
3.2.6 Flow cytometry 
3.2.6.1 Cell staining 
Surface staining of cells was performed in 96 V-well plates. About 2x105 cells were 
resuspended in 50 µl fluorescence-activated cell sorting (FACS)-buffer (PBS containing 
2 % FCS) containing 10 µg/ml of the respective primary antibody or indicated 
concentrations of fusion protein and incubated on ice for 20’. After washing with FACS-
buffer, cells were resuspended in 50 µl PE conjugated goat-anti-mouse secondary 
antibody diluted 1:200 in FACS-buffer. Cells were incubated on ice for 20’ in the dark to 
protect the fluorophore, washed again and resuspended in FACS-buffer containing 2 % 
formaldehyde. Samples were analyzed on a BD FACScan or BD FACSCalibur and results 
were evaluated using the FlowJo Software from Treestar. 
 
3.2.6.2 Quantification of surface molecules 
Surface molecules were quantified using the Qifikit (Dako) according to the 
manufacturer’s instructions. In brief, cell staining was performed as described but 
additionally, calibration beads were stained with the same solution of secondary 
antibody. Based on the mean fluorescence intensity (MFI) of the calibration bead 
populations a standard curve was generated and used to calculate molecule numbers on 
the stained cells. 
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3.2.7 Deglycosylation of NK cells 
Desialylation of cells was done using 1 µl Neuraminidase for 1x106 cells/100 µl PBS 
rotating 2 h at 37 °C, 5 % CO2. To inhibit elongation of O-glycosyl chains, cells were 
incubated with 2.5 mM BADG 48 h at 37 °C, 5 % CO2. De-N-Glycosylation was performed 
by incubating cells 12 h with 0.5 µg/ml tunicamycin at 37 °C, 5 % CO2. 
Cells were washed once with CTL medium (IMDM with 10 % FCS and 
penicillin/streptomycin) and used for flow cytometry, cytotoxicity assays or cell lysis. 
 
 
3.3 Protein biochemistry  
3.3.1 Nitrogen cavitation 
Nitrogen cavitation was done with a pre-cooled apparatus and magnetic stirrer. Before 
adding the samples, the magnetic stirrer was set on full power and all valves were 
closed. Cell-bead conjugates were resuspended in up to 10 ml but at least 1 ml of freshly 
prepared HB+ and transferred into the cavitation chamber. After closing the bomb and 
attaching all filling connections, the pressure was set to 1000 psi for 5’ - 7’, if not 
indicated differently. Samples were released by slowly opening the release valve and 
immediately retrieved using a 15 ml Falcon tube inserted in a magnet. The cavitation 
chamber was rinsed with 1 ml of HB and the tube filled up to 10 ml with HB. The tube 
was closed and inverted several times to release the beads from the foam. After an 
incubation period of 5’ in the magnet at 4 °C, the supernatant was removed completely 
by aspirating the foam first followed by decanting the supernatant. Washing was 
repeated twice with 10 ml HB and transferred into a 1.5 ml eppendorf tube by 
resuspending beads in 1 ml HB+. Beads were finally resuspended in 1 ml HB and counted 
using the Casy Cell Counter Model TT, “dried” by using the magnet and spinning down at 
10,000 rpm at 4 °C and resuspended in an appropriate volume of buffer (such as 2×RSB, 
CHAPS-, ASB-14 lysis buffer or similar) for the subsequent analysis procedure. 
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3.3.2 Nitrogen cavitation – sample preparation for 2D-DIGE 
For 2D-DIGE five samples of anti-2B4 and anti-NKG2A stimulation method were 
prepared. Therefore, 3x108 NKLs were stimulated for 5’ either with 1.5x108 anti-NKG2A 
or anti-2B4 coated magnetic beads and disrupted via nitrogen cavitation. The washed 
beads were counted and proteins were solubilized / eluted in CHAPS lysis buffer with the 
ratio [bead number]:[volume of lysis buffer] of 4:1. The pH was set to 9.0 and samples 
were frozen subsequently. For concentration determination 1 µl sample was taken and 
diluted 1:8 with buffer. Protein concentration was analyzed using the EZQ Protein 
Quantitation Kit, the protein amount was calculated and samples were adjusted to 
4 µg/µl. Samples were labeled using the CyDye DIGE minimal fluor protocol, separated 
via 2D-technique and gels were scanned and analyzed using the DeCyder software. 
 
3.3.3 Cell lysis with Triton X-100  
For Western blot analysis 1-2x107 cells/ml were lysed to obtain the required protein 
concentrations. Pelleted cells were resuspended in 0.5 % Triton X-100 lysis buffer 
supplemented with 1 mM PMSF and if necessary 1 mM Na-orthovanadate and incubated 
on ice for 20’. Lysates were clarified by centrifugation for 15’ at 20,000xg and 4 °C. If 
cells were stimulated with beads previously, beads were recovered before centrifugation, 
washed three times with Triton X-100 lysis buffer and resuspended in appropriate volume 
of buffer (such as 2×RSB, CHAPS-, ç14-lysis buffer or similar) for the subsequent 
analysis procedure. 
 
3.3.4 Immunoprecipitation 
Lysates of up to 2x107 cells were incubated for 1 h with 20 µl of goat-anti-mouse 
Dynabeads coated with 1.6 µg Isotype mAb (MOPC21) for preclearing and subsequently 
with specific antibody to isolate protein of interest. Samples were washed three times 
with ice-cold lysis buffer and residual buffer was removed completely using a magnet 
followed by spinning down the beads and aspirating remaining buffer. Beads were eluted 
by incubation in 2xRSB at 95 °C for 5’ or in ASB-14 or CHAPS containing lysis buffer by 
shaking at 18 °C for 20’, respectively. Samples were frozen at -20 °C until they were 
analyzed by SDS- or 2D-PAGE and Western blot. 
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3.3.5 Fusion proteins 
2B4-ILZ fusion proteins were produced and purified as described previously (Stark et al., 
2005; Watzl, 2006). Prior to protein elution from the agarose-beads, samples were 
divided and left untreated (2 h 4 °C) or enzymatically deglycosylated: For desialylation 
beads were incubated for 2 h at 37 °C with 17 µl Neuraminidase in PBS. Additional de-O-
glycosylation was achieved in a second approach using 10 µl O-Glycosidase together with 
the amount of Neuraminidase mentioned before. For ablation of N-glycosidic bound 
carbohydrates the same amount of beads were incubated overnight at 37 °C with 17 µl 
of PNGaseF in 50 mM Phosphatebuffer G7-Reactionbuffer. After treatment, beads were 
washed twice and proteins were eluted as described (Stark et al., 2005; Watzl, 2006). 
Protein concentration was quantified using the EZQ Protein Quantitation Kit. Purity was 
controlled via SDS-PAGE and silverstaining and successful deglycosylation via 2D-
gelelectrophoresis and Western blot, respectively. For 2D-gelelectrophoresis 100 ng 2B4-
ILZ fusion proteins were supplemented with ASB-14 lysis buffer up to 20 µl and 
processed as described below.  
 
3.3.6 Enzymatic deglycosylation and dephosphorylation of proteins 
Immunoprecipitated proteins were enzymatically treated directly on the magnetic beads. 
For dephosphorylation 8x106 beads were resuspended in 20 µl 1x NEB buffer 3 (New 
England Biolabs) and incubated 1 h at 37 °C with 2 µl Calf Intestine Phosphatase (CIP – 
New England Biolabs, Frankfurt). The same amount of beads were resuspended in 20 µl 
of 50 mM sodiumphosphate-buffer pH 7.4 with 1 µl of one of the following 
deglycosylation enzymes: PNGaseF for de-N-glycosylation (overnight 37 °C), 
Neuraminidase for desialylation (2 h, 37 °C) and Neuraminidase + O-Glycosidase for de-
O-glycosylation (2 h, 37 °C). 
 
3.3.7 Protein quantification  
Protein concentration was determined using a customized BSA standard and the EZQ Kit 
according to the manufacturer’s instructions. The membrane was analyzed on a FLA-
2000 (Inter Departmental Equipment, Haifa, Israel) using 473 nm excitation wavelength 
and 580 nm emission filter. 
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3.3.8 SDS-polyacrylamid gel electrophoresis (SDS-PAGE) 
After adding reducing sample buffer, samples were boiled for 5’ at 95 °C and centrifuged 
for 1’ at 20,000 x g. Samples to a maximal volume of 25 µl and 5 µl of Precision Plus 
Protein Standard (BioRad) were loaded on 10 % or 12 % NuPage gels (Invitrogen) and 
separated for 1 h 15’ at 150 V in 1 x MOPS buffer. 
 
3.3.9 2D-gelelectrophoresis (2D-PAGE) 
Bead eluates of 2B4-ILZ fusion proteins or receptors prepared by immunoisolation or 
immunoprecipitation were supplemented with 2xSB to a final volume of 100 µl and 
incubated for 20’ 18 °C and afterwards mixed with 100 µl Rehydration Solution. For 
isoelectric focusing (IEF) ReadyStrip IPG pH3-10 were used with the following conditions: 
50 µA per gel at 20 °C for all steps,  active rehydration at 50 V for 12 h, focusing: 15’ 
250 V (ramp: rapid), 2 h 4000 V (ramp: linear), 5 h 4000 V (ramp: rapid). About 
10 000 Vh were reached. IPG strips were equilibrated first in equilibration buffer I 
(containing 0.5 % (w/v) DTT), then in equilibration buffer II (with 4.5 % (w/v) 
iodacetamid, instead of DTT). Strips were placed on 4-12 % NuPAGE Bis-Tris ZOOM gels 
and overlayed carefully with melted 1 % low melting agarose prepared with 1xMOPS 
containing bromphenolblue. Proteins were separated for 1 h 15’ at 150 V in 1xMOPS 
buffer and transferred to a polyvinylidene difluoride (PVDF) membrane as described 
below. 
 
3.3.10 Western blot 
After SDS-PAGE proteins were transferred to a PVDF membrane for 1.5 h at 200 mA in 
Western blot transfer buffer. PVDF membranes were activated with methanol and washed 
with transfer buffer prior to use. After Western blotting, membranes were incubated for 
1 h at RT in blocking buffer and washed for at least three times in PBST. Membranes 
were incubated with the primary antibody for 1 h at RT or overnight at 4 °C. The 
membrane was washed at least three times with PBST/NaCl and incubated with the 
appropriate horseradish-peroxidase (HRPO)-conjugated secondary antibody for 1 h at 
room temperature. Secondary antibodies were diluted 1:5,000 - 1:40,000 in blocking 
buffer. After incubation with the secondary antibody, the membrane was extensively 
washed with PBST and developed using either SuperSignal West Pico or Dura and X-Ray 
films.  
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3.3.11 2D-DIGE (two-dimensional difference gelelectrophoresis) 
CyDye DIGE Fluor minimal dyes were prepared according to the manufacturer’s 
instructions (Ettan DIGE System User Manual, GE Healthcare). 50 µg protein were 
labeled with 1 µl of Cy3 or Cy5 working dye solution (400 pmol) and incubated on ice for 
30’ in the dark. Sample labeling was randomized by equal distribution of Cy3 and Cy5 to 
the different samples. The reaction was stopped by adding 1 µl of 10 mM lysine and 
incubation for 10’ on ice in the dark. A master mix of internal standard was prepared by 
mixing an appropriate volume of each sample to be sufficient for the final number of 
gels. Therefore, every protein from each sample is represented in the internal standard, 
which is present on all gels. The master mix of the internal standard was splitted into the 
corresponding number and stained as if they were samples, using Cy2 working dye 
solution. Samples were used immediately or stored up to 2 weeks at -80 °C. Cy3 and 
Cy5 samples and Cy2 internal standards were combined and an equal volume of 
rehydration solution was added and left on ice for 15’. DeStreak Rehydration Solution 
was added to a final volume of 450 µl and used for passive rehydration of Immobiline 
Dry Strips pH3-11 NL, for at least 10 h at RT in the dark. First dimension IEF was done 
according to the manufacturer’s instruction with the following setup: 1 h 200 V (step n 
hold), 1 h 500 V (step n hold), 9 h 1000 V (gradient), 1 h 1000 V (step n hold), 3 h 
8000 V (gradient), 3 h 8000 V (step n hold). About 45 950 Vh were reached. 12 % 
acrylamid gels were casted according to the manufacturer’s instructions. Strips were 
equilibrated in 1.5 ml equilibration buffer I and II for 15’ each. Strips were placed on the 
gels and overlaid carefully with melted 0.5 % low melting agarose prepared in SDS 
electrophoresis running buffer containing bromphenolblue. Gel cassettes were inserted in 
an Ettan DALTtwelve electrophoresis system filled with 1xSDS electrophoresis buffer in 
the lower chamber and 3xSDS electrophoresis buffer in the upper chamber. Proteins 
were separated with 1 W per gel followed by increasing the power up to 5 W per gel until 
the bromphenolblue dye front reach the end of the gel. Gel cassettes were scanned 
immediately using a Typhoon Variable Mode Imager according to the manufacturer’s 
instructions or stored for one day in 1xSDS electrophoresis buffer at 4 °C in the dark. 
Gels were fixed in fixation solution over night, stained with SYPRO Ruby over night and 
washed 30’ in wash solution and two times for 5’ in H2O. Image analysis was performed 
using the DeCyder 2D software and protein spots with significant difference in abundance 
(see also 4.1.4) were picked of three gels and combined for mass spectrometry analysis.  
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4 RESULTS 
4.1 Membrane microdomains surrounding NK cell receptors 
4.1.1 Establishing a new system: activation by antibody coated magnetic 
beads and cell disruption by nitrogen cavitation bomb 
4.1.1.1 2B4, NKp30 and NKG2D expression by NK cells 
To get an idea of the expression level of different NK cell receptors we analyzed NKL and 
NK92C1 cells via flow cytometry. In Figure 8A the surface expression of the NK cell 
receptors 2B4, NKp30 and NKG2D is measured using directly labeled antibodies. NKL 
expressed a moderate amount of 2B4, almost no NKp30 and NKG2D at a high level 
(Figure 8A, grey line). NK92C1 expressed a slightly higher amount of 2B4 than NKL, but 
a significantly higher level of NKp30, whereas the surface expression of NKG2D was 
moderate (Figure 8A, black line). To determine the number of receptors expressed on 
cell surface, a FACS based assay using commercially available calibration beads (Qifikit) 
was used. This kit allows for quantitative evaluation of surface epitopes by comparing 
fluorescences to calibrated beads. Figure 8B illustrates a representative experiment. 
Comparable with the directly stained cells in Figure 8A, NKG2D was expressed higher by 
NKL cells, whereas 2B4 and NKp30 were mainly expressed by NK92C1 cells. NKG2A, as 
part of the CD94/NKG2A inhibitory heterodimer, showed with a value of 5x104 the 
greatest amount of molecules per cell. 
Therefore, both assays depict the same receptor expression profile of NKL and NK92C1 
cells, respectively.  
  
Figure 8: Receptor expression on NK cell lines. A NKL (grey line) and NK92C1 (black line) 
cells were stained with directly labeled antibodies against 2B4, NKp30 and NKG2D and analyzed via 
flow cytometry. Isotype control of stained NKL cells is shown as filled histogram.  
B Representative quantification of surface molecules on NKL (grey bars) and NK92C1 (black bars) 
cells. Total amounts of molecules were determined using a FACS based calibration assay (Qifikit). 
Calculation was done according to the manufacturer’s instructions.  
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4.1.1.2 Binding of antibody coated magnetic beads to cells 
Analyzing membrane receptors and their associated cytoplasmic regions requires the 
precise binding and stimulation with antibody coated magnetic beads and exclusion of 
unspecific cell interaction.  
In our system, ongoing stimulation of cells is stopped by adding ice-cold HB buffer after a 
defined period of incubation at 37 °C. To obtain a “zero” value, where cell-bead contacts 
are made, but no receptor activation takes place, incubation was performed at 4 °C. 
While maximal binding with specific antibody-coated beads should be achieved, isotype 
loaded beads should not bind at any condition. We tested different buffers for their ability 
to facilitate maximal binding of anti-2B4 coated magnetic beads to NKL cells at 4 °C and 
analyzed cell-bead contacts as described in materials and methods (Figure 9).  
 
 
 
 
 
 
 
 
 
Figure 9: Cell-bead contact formation using different buffers. NKL cells were incubated with 
anti-2B4 (α-2B4) or isotype (Iso) coated beads for 10’ at the indicated temperatures and contact 
formation was stopped with HB buffer containing the indicated amounts of NaCl and sucrose 
(Sucr). Contacts per bead (dark grey bars) and contacts per cell (light grey bars) were analyzed 
and calculated as described in materials and methods. Contacts after incubation of cells with anti-
2B4 coated magnetic beads at 37 °C, stopped with an HB buffer containing 150 mM NaCl and 
50 mM sucrose were set as 100 % and other values were calculated accordingly.  
 
Beads always comprise half of the number of NK cells. This means that the bead to NK 
cell ratio was set to 1:2 in all experiments. The number of beads and cells as well as 
contacts between both were counted and the ratio of contacts per bead and the ratio of 
contacts per cell was determined. 10’ of incubation at 37 °C serves as positive control. 
These values were set as 100 %, whereas incubation with isotype coated beads under 
the same conditions serves as negative control.  
At 37 °C almost every bead was connected to at least one NK cell, whereas not every NK 
cell was able to form a contact (data not shown). This setup was chosen to reduce side 
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effects resulting from two or more NK cell synapses on one cell. Incubation at 4 °C 
diminished contact formation by NK cells.  
A good binding of anti-2B4 coated magnetic beads by NKL could be observed by using HB 
buffer completed with 150 mM NaCl and 50 mM sucrose at 37 °C. In contrast, almost no 
contacts were found using isotype loaded beads (5 and 4 %) or at an incubation 
temperature of 4 °C for stimulating beads (0 %) (Figure 9, first three bars). Utilizing 
buffers with decreasing amount of NaCl from 150 mM over 100 mM to 50 mM increased 
the contact ratio from 0 % up to 5/6 % or 20/27 %, respectively. Increasing the sucrose 
content from 50 mM to 250 mM also led to an increase of contact formation at 4 °C 
(Figure 9). 
Thus, best binding of anti-2B4 coated magnetic beads to NKL cells at 4 °C occurs by 
stopping the interaction with HB buffer containing 50 mM NaCl and 250 mM sucrose. This 
buffer did not increase isotype control binding (data not shown) and therefore used for 
the following stimulation and isolation methods. 
Different surface expression levels as shown in Figure 8 may influence the binding 
capacity of NK cells to antibody coated magnetic beads. To examine, if NKL and NK92C1 
discriminate between different antibody coated beads, cells were stimulated for 5’ at 
37 °C and cell-bead contacts were counted. As illustrated in Figure 10A, the bead:cell 
ratio was adjusted to 0.5 (black bars) as described in materials and methods. NK cells 
constantly formed less than one contact to the magnetic beads (ratio < 1.0, light grey 
bars).  
 
 
 
 
 
However, the beads sometimes were attached to more than one cell, as seen by an 
average contact per bead ratio greater than 1.0 (dark grey bars). Isotype loaded 
magnetic beads did neither bind to NKL cells nor to NK92C1 cells. Despite this, a good 
binding could be observed using anti-2B4 and anti-NKG2D-coated beads for NKL cells, as 
well as anti-2B4 and anti-NKp30 beads for NK92C1 cells. When comparing the results 
with the FACS staining in Figure 8 this is an interesting observation due to the fact, that 
Figure 10: Binding of antibody coated magnetic beads to NK cells.  Differentially antibody 
coated magnetic beads were incubated with NKL or NK92C1 cells for 5’ at 37 °C and contact 
formation was blocked with ice cold HB buffer as described in materials and methods. Black bars 
indicate ratio between beads and cells, dark grey bars contacts per bead and light grey bars 
contacts per cell. 
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2B4 was expressed in higher quantity by NK92C1 cells but anti-2B4 coated beads were 
better attached to NKL cells. According to the FACS data, NKL cells bound anti-NKp30 
coated beads very weakly, whereas no binding of anti-NKG2D coated beads to NK92C1 
cells could be observed, even if low expression of this receptor was detectable. 
Hence, surface expression as detected by FACS-based assays is not necessarily in 
agreement with binding behavior of NK cells to antibody coated beads. We chose to carry 
our experiments on in NKL cells, as the 2B4/NKL pair appeared to be the optimally suited 
system for our study. 
 
4.1.1.3 Bead based stimulation leads to a functional and specific outcome 
To test if engaged receptors induce signaling, 2x106 NKLs were stimulated with isotype 
or anti-2B4 coated magnetic beads for 7’ at 37 °C and disrupted via nitrogen cavitation 
as described in materials and methods and schematically in Figure 11A. Incubation with 
isotype coated magnetic beads and recovering of those did not lead to any receptor 
isolation. However, using anti-2B4 coated magnetic beads to stimulate NKLs, the 
receptor could be isolated successfully (Figure 11B (1) vs. (2), middle panel). The same 
was true for immunoprecipitation of 2B4 from the remaining cell lysates (Figure 11B (3), 
(4), middle panel), which means that not all receptors were engaged by this method. In 
contrast to the receptors remaining unstimulated, the engaged ones exhibited 
phosphorylation as demonstrated by reprobing the membrane with anti-phosphotyrosine 
antibody (Figure 11B (1) vs. (2), top panel). Thus, only the stimulated 2B4 is 
phosphorylated. The remaining receptors are not affected by coincubation of cells with 
magnetic beads. Interestingly, 2B4-immunoprecipitations from lysates of isotype 
stimulated samples seem to contain more residual receptors than the receptor stimulated 
and immunoisolated and thereby “receptor-diminished” lysates.  
In order to test for functionality of antibody coated bead stimulation, NKL cells were 
incubated for 16 hours with magnetic beads and supernatants were analyzed for IFN-γ. 
As seen in Figure 11B, only the anti-2B4 coated magnetic beads stimulated NKL cells to 
produce IFN-γ. Neither uncoated (Ctrl) nor isotype loaded beads were able to activate 
NKL cells, even after overnight incubation.  
In summary binding of as well as stimulation with antibody coated magnetic beads 
occurs receptor specific and leads to receptor specific as well as functional NK cell 
stimulation. 
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Figure 11: Bead based stimulation leads to specific and functional outcome. A Flow chart 
illustrating sample preparation. NKL cells were stimulated with isotype (1) or anti-2B4 (α-2B4) (2) 
coated magnetic beads for 7’ at 37 °C and disrupted via nitrogen cavitation. Beads were recovered 
and washed [A]. The remaining cell residues were additionally treated with Triton X-100 for 20’ at 
4 °C and remaining 2B4 receptors were immunoprecipitated [B]. B Samples prepared as described 
in A were analyzed by Western blotting. Membranes were probed with anti-phosphotyrosine 
antibody to detect receptor phosphorylation (middle panel) and with antibodies against 2B4 (upper 
panels). LC determines the light chain of the anti-2B4 antibodies used for immunoisolation or 
immunoprecipiation (C1.7 see materials and methods) and was visualized by the anti-mouse 
secondary antibody. Depicted is one representative result of two experiments.  
C NKL cells were stimulated 16 hours with unloaded (Ctrl) or antibody coated (Iso=isotype, anti-
2B4) magnetic beads and IFN-γ amount was measured and calculated as described in materials 
and methods. 
 
4.1.1.4  2B4 stimulation by antibody coated magnetic beads leads to receptor 
phosphorylation and signal molecule recruitment 
One of the first signaling events after 2B4 engagement is the rapid phosphorylation of 
the receptor by Src kinases. To test, if in our system 2B4 phosphorylation takes place in 
a time dependent manner, we incubated NKL and antibody coated beads for up to 10’ at 
37 °C and analyzed the bead-content after lysis with TX-100 buffer (Figure 12A). 
Phosphorylation of 2B4 occurred as soon as after 5’ and increased up to 10’ of 
stimulation. The isotype coated beads did not isolate any receptor molecules.  
A further important feature of 2B4 is its function as costimulatory receptor for other 
activating receptors, for example NKG2D. Mostly, costimulation by 2B4 results in a 
synergistical enhancement, which means an amplification of the signal rather than the 
mere addition of both signals alone. The guanine exchange factor (GEF) molecule Vav1 
acts as decision point during activation of NK cells by integrating the in-coming signals 
from different receptors into further downstream events. Vav1 is recruited via the 
adaptor molecule growth factor-bound protein (Grb)2 to the cytosolic domain of the 
NKG2D adaptor molecule Dap10, thereby completing the signaling complex. 2B4 is able 
to enhance Vav1 phosphorylation, however it transduces signals by other adaptor 
molecules (SAP, 3BP2) as NKG2D.  
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To test, if receptor engagement in our system could confirm previously reported signaling 
pathways we stimulated NKL cells for 5’ at 37 °C with antibody coated magnetic beads 
and analyzed the bead content after TX-100 lysis via SDS-PAGE and Western blotting, 
respectively. Stimulation of 2B4 alone led to the expected receptor phosphorylation 
(Figure 12B – second lane) as already seen before (Figure 12A + Figure 11). However, 
even if SAP association was reported to be crucial for 2B4-mediated signaling, it could 
not be detected in our setup (data not shown). Vav1 association was detectable, whereas 
its phosphorylation could not be confirmed. Furthermore, a tyrosine phosphorylated 
protein with molecular weight of 16 kDa appeared. In contrast to this, stimulation with 
anti–NKG2D coated magnetic beads led to proper receptor and Vav1 isolation as well as 
adequate Vav1 phosphorylation (Figure 12B – lane 3). A phosphorylated protein at 
16 kDa could be detected, too, whereas an additional band appeared at 14 kDa.  
So far, we analyzed the outcome of single receptor stimulation. To test, if 2B4 
stimulation is able to contribute to proper Vav1 phosphorylation, we used double 
antibody coated beads to stimulate both receptors simultaneously. However, by using 
double antibody coated beads, only half of the bead surface is coated with anti-NKG2D 
antibodies and therefore receptor engagement is diminished per se. Using anti-NKG2D 
and isotype double coated beads could give an idea to which extent NKG2D engagement 
is able to lead to Vav1 phosphorylation. As seen in Figure 12 lane 4, Vav1 association still 
occured, whereas phosphorylation of the GEF was diminished. Interestingly, NKG2D 
isolation was not impaired even if only half of the bead surface is covered with anti-
NKG2D antibody. Furthermore, the stimulation seems to be insufficient to isolate the 
small phosphoproteins that have been seen before. As we now have a reference with 
which we can compare additional 2B4 engagement, we coated beads with anti-2B4 and 
anti-NKG2D at once. As expected, simultaneous engagement of both receptors led to less 
2B4 receptor isolation as compared to single stimulation (Figure 12 lane 2+5). The 
amounts of the NKG2D receptor as well as of Vav1 were comparable with the anti-
NKG2D/isotype double coated beads. Interestingly, Vav1 was phosphorylated to a 
greater extend as when using the anti-NKG2D/isotype control and even more in 
comparison to single anti-NKG2D coated magnetic beads. According to single stimulation, 
a 16 kDa phosphoprotein could be coisolated again.   
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Figure 12: Outcome of 2B4 stimulation. A NKL cells were stimulated with isotype or anti-2B4 
coated magnetic beads for 0’, 5’ or 10’ at 37 °C and lysed with Triton X-100 lysis buffer. Beads 
were recovered and protein contents were analyzed by Western blotting. Membranes were probed 
with anti-phosphotyrosine antibody to detect 2B4 phosphorylation (p2B4), anti-2B4 (α-2B4) to 
visualize receptor amount, as well as anti-mouse secondary antibodies to detect the light chain 
(LC) of the anti-2B4 coated magnetic beads, respectively. B NKL cells were stimulated with 
antibody coated beads (indicated on top) for 5’ at 37 °C and lysed with Triton X-100 lysis buffer. 
Contents of the recovered beads were analyzed by Western blotting. 2B4 phosphorylation (p2B4) 
as well as the tyrosine phosphorylation (pTyr) were detected after reprobing the membrane with 
the 4G10 antibody. C+D IFN-γ amount after overnight stimulation. NKL cells were stimulated for 
12 h with the indicated antibody coated beads and supernatants were tested for IFN-γ production 
using the BMS ELISA as described in materials and methods. In C the outcome of costimulation 
and in D the outcome of inhibition are shown. Results are representative for at least three 
experiments. 
 
In summary, the outcome of costimulation by double antibody coated magnetic beads 
could be verified already on the level of enhanced Vav1 phosphorylation. But does this 
synergy among 2B4 and NKG2D also lead to enhanced NK cell stimulation?  
To answer this question, the same setup was used to stimulate NKL cells over night and 
to analyze the released IFN-γ amount. Incubation of cells with anti-2B4/isotype loaded 
beads resulted in a 7-fold and use of anti-NKG2D/isotype loaded beads in an even 19-
fold cytokine secretion compared to the isotype control (Figure 12C). Synergistic 
stimulation of 2B4 and NKG2D together resulted in a 42-fold induction of IFN-γ secretion, 
which cannot be the result of a merely additive effect of each receptor itself. 
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Important for the regulation of NK cells is an efficient inhibition to suppress activation 
and thereby prevent uncontrolled cytotoxicity. As depicted in Figure 12D, engagement of 
the inhibitory receptor NKG2A did not induce the secretion of IFN-γ, in contrast to 2B4 
engagement. More importantly, by triggering the inhibitory NKG2A receptor in concert 
with 2B4 via double coated beads, we could further decrease the released IFN-γ up to 
-89 %. Consequently, in addition to the synergy among the activating receptors 2B4 and 
NKG2D, the inhibition of NK cells via engagement of the inhibitory receptor NKG2A could 
be confirmed. 
 
4.1.1.5 Size reduction of membrane microdomains 
One critical point for the identification of downstream signaling events occurring after 
receptor engagement, is the size and thereby the definition of membrane microdomains. 
The method of immunoisolation used here is a less invasive technique concerning the 
“natural” composition of membrane microdomains. However, a critical point is the 
inhomogeneity and the unknown size of the isolated membrane fragments after nitrogen 
cavitation. To investigate, if we could reduce the amount of contaminating membrane 
proteins, we chose to focus on the association of CD45, a critical non-lipid raft marker, 
and varied the pressure onto the cells in the nitrogen cavitation bomb to reduce the size 
of extracted fragments. As seen in Figure 13, increasing the pressure from 500 up to 
1200 psi did not lead to a complete ablation of CD45 from the anti-2B4 isolated lipid 
isles. Nevertheless, at 1000 psi the amount of CD45 was reduced sufficiently without any 
reduction in 2B4 amount. Therefore we decided to continue the experiments with a 
pressure size of 1000 psi. 
 
Figure 13: Size reduction of membrane 
microdomains. NKL cells were stimulated with anti-
2B4 coated magnetic beads for 5’ at 37 °C and 
subsequently disrupted via nitrogen cavitation with 
varied pressure (500 – 1200 psi) to minimize size of 
membrane fragments. Beads were recovered and 
protein contents were analyzed by Western blotting. 
Membranes were probed with anti-CD45 and anti-2B4 
and appropriate secondary antibodies to detect the 
characteristic non-raft marker CD45, the engaged 2B4 
receptor and light chain (LC) of the anti-2B4 coated 
magnetic beads, respectively. 
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4.1.2 Phosphoproteomics: A multiplicity of different phosphorylated proteins 
Protein phosphorylation is an important post-translational modification, which is essential 
for many cellular functions (Gnad et al., 2007). Analysis of this key mechanism can be 
performed by separating proteins with 2D-gelelectrophoresis and subsequently detection 
of phosphotyrosines via immunoblotting. Stimulation of 2B4 triggers many signaling 
molecules in order to achieve NK cell activation. Neither the mechanism, nor the 
chronology of these processes are completely understood. The method of 
immunoisolation using the nitrogen cavitation bomb enables us to analyze spatially 
restricted events directly after receptor triggering.  
NKL cells were stimulated with anti-2B4 coated magnetic beads at 37 °C for 2’ or 10’ and 
subsequently disrupted via nitrogen cavitation. Samples were divided into two parts and 
proteins were separated by 2D-gelelectrophoresis to check each sample separately for 
protein amount and phosphorylation status using silver staining and anti-
phosphotyrosine Western blotting, respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: Phosphoproteomics. NKL cells were stimulated with anti-2B4 coated magnetic beads 
for 2’ (top) or 10’ (bottom) at 37 °C and disrupted via nitrogen cavitation. Beads were recovered 
as described in materials and methods. Samples were divided into two parts and bead contents 
were separated using 2D-gelelectrophoresis. One gel of each sample was silver stained (left panel), 
the other one analyzed via Western blotting using the 4G10 antibody to detect phosphotyrosine 
(right panel). Red squares indicate spots appearing in both samples (2’ and 10’) with both silver 
staining and Western blot. Blue circles mark distinct outcomes of stimulation, mainly detectable in 
the anti-phosphotyrosine Western blot.   
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As illustrated in Figure 14, left panel, the protein content after 2’ of stimulation does not 
or only marginally differ from the composition of longer stimulated cells. However, 
protein phosphorylation increased and also shifted to more low-molecular mass proteins 
as shown in Figure 14, right panel. Some spots appeared in the silver staining as well as 
in the anti-phosphotyrosine Western blot of both differentially stimulated samples (red 
square) whereby other spots could be detected with silver staining although the 
phosphorylation occured only after a longer time of stimulation (blue circles). Therefore, 
time dependent stimulation with antibody coated magnetic beads and subsequent 
disruption of cells by nitrogen cavitation results in the immunoisolation of the same 
amount of membrane microdomain adjacent proteins. In contrast, phosphorylation as 
indicator of proceeding signaling cascade increases as expected. 
 
4.1.3 Effect of inhibition and activation - 2D-PAGE 
The activating NK cell receptor 2B4 is recruited into DRMs after receptor engagement 
(Watzl et al., 2003; Watzl et al., 2000). To identify proteins involved in raft recruitment, 
immunoisolation using the nitrogen cavitation bomb should help to gain further insights 
into the natural composition of 2B4 containing membrane microdomains as well as 
adjacent signaling molecules. As not only raft associated proteins are isolated with this 
method, we need a receptor which is not recruited into lipid rafts. It has been shown, 
that the inhibitory receptor CD94/NKG2A is excluded from lipid rafts, even after receptor 
ligation (Sanni et al., 2004). Therefore we decided to compare immunoisolated samples 
of the activating receptor 2B4 with those of the inhibitory NK cell receptor CD94/NKG2A. 
To get an idea, which proteins are uniquely involved in 2B4 mediated signaling we 
separated immunoisolated proteins with 2D-gelelectrophoresis. Additionally we also could 
get information about signaling pathways after engagement of inhibitory NK cell 
receptors.  
NKL cells were stimulated with anti-2B4 or anti-NKG2A coated magnetic beads and 
immunoisolated proteins were separated via 2D-PAGE followed by silver staining. As 
shown in Figure 15, many proteins could be isolated by this mechanical cell disruption 
method. 
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Figure 15: Inhibition versus activation. NKL cells were stimulated 5’ at 37 °C with antibody 
coated magnetic beads to engage 2B4 or NKG2A (as part of the inhibitory receptor CD94/NKG2A) 
and disrupted via nitrogen cavitation. Beads were eluted in CHAPS-containing lysis buffer and 
samples were separated using 2D-gelelectrophoresis. Gels were silver stained. Differences are 
indicated and shown in higher magnification with blue circles whereas one example for spot 
similarity is given by an enlarged square. 
 
Although most spots were comparable between both samples (marked by a square) 
significant differences were visible (marked by a circle). In evidence, spots completely 
disappeared or seemed to be isolated in a greater amount when comparing both gels. To 
improve sensitivity and accuracy and thereby getting more precise and “true” information 
about the differences between activating and inhibitory signals, we switched to two-
dimensional difference gelelectrophoresis (2D-DIGE). 
 
4.1.4 Effect of inhibition and activation - 2D-DIGE 
An advantage of 2D-DIGE is the comparison of two samples in one gel by utilizing an 
internal standard. This also allows for the comparison between gels with only minor gel-
to-gel variation. We optimized our system for ideal means of protein concentration and 
solubilization and performed 2D-DIGE experiments with the settings obtained. We chose 
to compare five samples in parallel after stimulation via anti-NKG2A or anti-2B4 coated 
magnetic beads.  
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Figure 16 shows an example for one protein of interest (POI), whereas the colors blue 
and green mark the NKG2A and 2B4 sample, respectively.   
 
 
 
Figure 16: Inhibition versus activation: Analysis of one protein of interest (POI) using 
the DeCyder software. NKG2A (representing NK cell inhibition) and 2B4 (representing NK cell 
activation) samples were prepared as described in materials and methods. Spots were detected 
and quantified using the DeCyder software. Shown is one representative POI analyzed in the 
Biological Variation Analysis (BVA) module to perform statistical analysis to assess treatment 
difference. The NKG2A sample of gel#1 is marked blue and the 2B4 sample of gel#1 is marked 
green. A demonstrates the purple marked POI in the image view. Samples of NKG2A stimulated 
cells are shown on the left side, whereby the right panel represents samples of 2B4 stimulated 
cells. Each pair, read from top to bottom, represent one gel, indicated by numbers. B shows the 
same POI of gel#1 as in A in three-dimensional view. C compares the depicted POIs shown in A 
with the internal standard of every gel, set zero. Each circle represents a different sample of a 
different gel, whereas the NKG2A and 2B4 sample of gel#1 are colored as before. 
 
In Figure 16A the image view illustrates a magnification with a purple marked POI. Even 
though most protein spots do not differ, differences in spot intensities between the 
NKG2A and 2B4 samples are obvious. Figure 16B demonstrates the same POI of gel#1 
as three-dimensional view. By using an internal standard on each gel, the samples are 
quantitatively comparable. This is shown with a graphical view in Figure 16C, where the 
standards of every gel were set to zero and the POI intensities were calculated 
accordingly. The POI shown already in Figure 16A+B is marked again blue for NKG2D 
and green for 2B4.  
A total of 23 spots were statistically relevant. To define a protein of interest, t-test values 
smaller than 0.05 were chosen. The resulting list was sorted by average ratio and spots 
were confirmed when it was greater than 1.2. Some spots were added manually, even if 
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the average ratio was not greater than ±1.1, when they seemed relevant in graphical 
view. Because the sample material was limited and no preparative gel was prepared, 
proteins were picked out of three analytical gels and pooled to get the required amount 
of protein for MALDI or ESI analysis. 
 
4.1.5 Inhibition and stimulation: proteins involved in signaling processes  
Table 1 summarizes the identified proteins, which may be relevant for the analyzed 
processes. The complete list of identified proteins is attached at the end of this thesis. 
Most proteins were identified by ESI spectrometry due to limited protein amount and 
overlapping spectra of several proteins as a result of the picking strategy.  
Sample 
IDa Protein Name
b T-testc Av. Ratiod 
Prot. 
scoree 
Prot. 
Mass 
[Da]f 
pIf No. of hitsg   
Prot. 
Nr. 
          
  2** ezrin [Hs] 0.021 1.38 236 74118 6.46 5  1 
  3 
protein phosphatase 3, 
catalytic subunit, alpha isoform 
isoform 1 [Hs] 
7.1x10-4 2.44 39 58262 5.90 1 k 7 
  3 phospholipase C-alpha (protein disulfide-isomerase A3) [Hs] 7.1x10
-4 2.44 34 57044 6.38 2 m 8 
  4* chaperonin containing TCP1, subunit 2 [Hs] 1.8x10
-3 1.54 460 57794 6.01 14  1 
  7** FK506 binding protein 5 [Hs] 0.035 1.50 514 51693 5.70 14  1 
  7** chaperonin containing TCP1, subunit 2 [Hs]   108 57753 5.97 3  4 
11 Rho GDP dissociation inhibitor (GDI) beta [Hs] 0.045 1.16  23031 4.9 52%   
12 calpain, small subunit 1 [Hs] 7.9x10-3 1.27  28469 4.9 25%   
17** chaperonin containing TCP1, subunit 2 [Hs] 6.6x10
-5 4.77 94 57753 5.97 1 k 6 
17** chaperonin [Hs]   40 59004 5.48 1 k 11 
18 chaperonin [Hs] 0.019 1.16 42 59004 5.48 1 k 8 
18 chaperonin containing TCP1, subunit 2 [Hs]   34 57753 5.97 1 
k 9 
21* growth factor receptor-bound protein 2 isoform 1 [Hs] 6.2x10
-6 -4.51 175 23655 6.31 9  3 
32 FK506 binding protein 5 [Hs] 1.8x10-3 2.72 109 51693 5.70 4  6 
 
Table 1: Identified proteins chosen by their relevance.  
aDue to picking strategy (see text) and ESI analysis, some protein spots exhibit more than one 
protein, whereas the table depicts only the cytoplasmic and possible relevant proteins. The 
complete list is attached at the end of this thesis. *marks the identification of Ig [mus musculus] 
identifications, which were of low significance but with always lower number of hits than the 
depicted protein. **markes the identification of Ig [mus musculus] peptides, however being non-
significant due to less number of hits. 
bProtein name derived from PubMed. [HS] means homo sapiens.  
cp value calculated using the Student’s T-test.  
dAverage ratio between 2B4 and NKG2A (>1  greater extend in the 2B4 samples; <-1 greater 
extend in the NKG2A samples.  
eProbability-based Mascot scores 
fTheoretical molecular mass (Da) and pI from the ExPASy database. 
gNumber of hits resulting from ESI analysis. Percent values indicates sequence coverage of MALDI 
analysis. 
k illustrates that only one peptide was identified which might not be significant 
m single peptide score non-significant, sum of single peptide scores significant  
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In Table 2 the identified proteins are grouped according to their relevance for localization 
or function. 
Sample 
IDa Protein Name
b T-testc Av. Ratiod Subcellular location
e Functione 
      
  2** ezrin [Hs] 0.021 1.38 cytoplasm / peripheral membrane 
cytoskeleton 
remodeling 
11 Rho GDP dissociation inhibitor (GDI) beta [Hs] 0.045 1.16 cytoplasm GTPase activation 
12 calpain, small subunit 1 [Hs] 7.9x10-3 1.27 cytoplasm / peripheral membrane 
cytoskeleton 
remodeling 
21* growth factor receptor-bound protein 2 isoform 1 [Hs] 6.2x10
-6 -4.51 cytoplasm signal transduction 
  3 protein phosphatase 3, catalytic subunit, alpha isoform isoform 1 [Hs] 7.1x10
-4 2.44 cytoplasm, nucleus cell cycle, cell devision 
  3 phospholipase C-alpha (protein disulfide-isomerase A3) [Hs] 7.1x10
-4 2.44 cytoplasm, ER, golgi isomerase, protein transport 
  4* chaperonin containing TCP1, subunit 2 [Hs] 1.8x10
-3 1.54 cytoplasm protein folding 
  7** FK506 binding protein 5 [Hs] 0.035 1.50 cytoplasm, nucleus protein folding 
  7** chaperonin containing TCP1, subunit 2 [Hs] 0.035 1.50 see above see above 
32 FK506 binding protein 5 [Hs] 1.8x10-3 2.72 see above see above 
17** chaperonin containing TCP1, subunit 2 [Hs] 6.6x10
-5 4.77 see above see above 
17** chaperonin [Hs]   see above see above 
18 chaperonin [Hs] 0.019 1.16 see above see above 
18 chaperonin containing TCP1, subunit 2 [Hs]   see above see above 
 
Table 2: Identified proteins sorted by localization and function 
aDue to picking strategy (see text) and ESI analysis, some protein spots exhibit more than one 
protein, whereas the table depicts only the cytoplasmic and possible relevant proteins. The 
complete list is attached at the end of this thesis. *marks the identification of Ig [mus musculus] 
identifications, which were of low significance but with always lower number of hits than the 
depicted protein. **markes the identification of Ig [mus musculus] peptides, however being non-
significant due to less number of hits. 
bProtein name derived from PubMed. [HS] means homo sapiens.  
cp value calculated using the Student’s T-test.  
dAverage ratio between 2B4 and NKG2A (>1  greater extend in the 2B4 samples; <-1 greater 
extend in the NKG2A samples.  
eInformations about subcellular location and function from UniProtKB and NCBI databases 
 
 
The relevant proteins ezrin, Rho GDP dissociation inhibitor (Rho GDI) beta, calpain, small 
subunit 1 as well as growth factor receptor-bound protein2 isoform 1 (Grb2) will be 
further debated in the discussion part.  
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4.2 Glycosylation of 2B4 and its effect in ligand binding and function 
Glycosylation is an important posttranslational modification of lipids and proteins. Their 
diversity reflects their multiple biological functions beginning with the recognition of 
pathogens, cell differentiation, development, trafficking, cell-cell communication and also 
intracellular processes. 2B4 is an important activating receptor for the regulation of NK 
cell response. 2B4 contains several N-glycosylation sites (Tangye et al., 1999) which may 
impair or influence positively the interaction with its ligand CD48. The second part of this 
thesis aims for the characterization of posttranslational modifications especially 
glycosylation of the activating NK cell receptor 2B4 and its influence in functionality. 
 
4.2.1 2B4 is a highly glycosylated receptor 
To study, if different NK cells exhibit different posttranslationally modified 2B4 receptors 
we immunoprecipitated the protein from different NK cells and stably 2B4 transfected 
HEK-293T (HEK-2B4) cells and analyzed it via 2D-gelelectrophoresis and Western 
blotting. The 2B4 receptor migrated at an apparent molecular weight of about 70 kDa in 
all cells analyzed and showed distinct spots over a broad pH range (Figure 17A). The spot 
pattern between 2B4 molecules from primary NK cells, the NK cell line NKL and HEK-2B4 
cells were comparable whereas the NK cell line NK92C1 expressed a more alkaline 
receptor.  
 
 
 
 
 
 
2B4 contains four ITSM domains important to fulfill its function. Phosphorylation replaces 
neutral hydroxyl groups with negatively charged phosphates. This results in a shift 
towards acidic pH. To test whether the differences in pH could be due to background 
phosphorylation of the four cytoplasmic ITSM domains, immunoprecipitated 2B4 proteins 
were dephosphorylated using Calf Intestinal Phosphatase (CIP). While this treatment led 
to a complete dephosphorylation of 2B4 as evident by anti-phosphotyrosine blotting 
(data not shown), it only resulted in a marginal shift of the whole spot pattern towards a 
Figure 17: 2B4 is highly glycosylated. 2B4 was immunoprecipitated from primary NK, NKL, 
NK92C1, HEK-2B4 cells and analyzed using 2D-gelelectrophoresis and anti-2B4 Western blotting. 
Samples were left untreated (A) or dephosphorylated using Calf Intestinal Phosphatase (CIP) (B). 
Representative results of four experiments are shown. 
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more basic pH (Figure 17B). This indicates that phosphorylation has only minor influence 
in the diversity of 2B4 receptor spot pattern.  
To further confirm that phosphorylation is only partially responsible for the diverse spot 
pattern of 2B4, we expressed wildtype 2B4 (wt) as well as a construct with tyrosine to 
phenylalanine mutations in all ITSM (Y1,2,3,4F) in HEK-293T cells. As illustrated in Figure 
18A the mutation of all ITSM tyrosines led only to minor reduction in spot diversity 
compared to the 2B4 wildtype construct. Pervanadate treatment of HEK-293T cells again 
resulted in a shift towards acidic pH for the wildtype construct, whereas the mutant form 
did not change its spot distribution (Figure 18B). Furthermore, the absence of all four 
ITSM tyrosines in the mutant form did not lead to phosphorylated 2B4 as depicted by the 
anti-phosphotyrosine Western blot (Figure 18C).  
 
 
 
 
 
 
 
 
Hence, phosphorylation of the ITSM domains of 2B4 leads to a further shift of the spot 
pattern towards acidic pH, whereas complete dephosphorylation does not lead to an 
abolishment of spot diversity. These results allow for the assumption, that 2B4 is a highly 
glycosylated receptor. 
 
4.2.2 2B4 is highly N-glycosylated 
Human 2B4 contains eight possible N-glycosylation sites. To test whether 2B4 is N-
glycosylated and if N-glycosylation differs between the examined cell populations, the 
immunoprecipitated receptor was dephosphorylated using CIP or additionally de-N-
glycosylated using PNGaseF. Removal of N-glycans reduced the mass of 2B4 to the 
predicted molecular weight of 39 kDa (Figure 19A, B). Interestingly, the spot patterns 
between the different cell lines were comparable after PNGaseF treatment (Figure 19B). 
Figure 18: Spot pattern of 2B4 is not due to phosphorylation. HEK-2B4 cells or HEK cells 
transfected with 2B4-ITSM mutant (Y1,2,3,4F) were incubated 10’ at 37 °C in PBS (PBS (A)) or in 
PBS containing Pervanadate (Pervanadate (B+C)) to block phosphatase activity. Cells were lysed 
and 2B4 was immunoprecipitated. Samples were separated using 2D-gelelectrophoresis and 
analyzed via Western blotting. Blottet membranes were probed with anti-2B4 antibody (α-2B4 
(A+B)) and reprobed with 4G10 antibody to detect phosphotyrosines (α-phospho-Tyr (C)). 
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This suggests that N-linked carbohydrates on 2B4 differ between NK92C1 and the other 
NK cells analyzed. It further shows that N-linked sugars account for the 30 kDa 
difference between calculated and apparent molecular weight of the 2B4 receptor. 
However, the 2B4 receptor still migrated as distinct spots covering a broad pH range 
after the removal of N-glycans. This suggested the presence of additional sugar moieties 
that are highly charged and of small size. 
 
 
 
 
 
 
4.2.3 2B4 contains sialic acids and O-linked carbohydrates 
Sialic acids are highly negatively charged and therefore shift the pH of proteins towards 
acidic pI with only minor change in molecular mass. To test for the presence of sialic 
acids on 2B4, we desialylated immunoprecipitated 2B4 using Neuraminidase. 
Desialylation shifted the pH of immunoprecipitated 2B4 to its calculated pI of 9.61 
(Figure 20A, B). Additional removal of O-linked glycans did not change the pI further 
(Figure 20C). Instead, we sometimes observed a slight increase in molecular weight of 
the 2B4 receptor. These data show that the distinct spot pattern of 2B4 is caused by 
sialic acid residues on N- and O-linked sugars. 
 
Figure 19: 2B4 is highly N-glycosylated. Immunoprecipitated 2B4 from NKL, NK92C1 or HEK-
2B4 cells was either dephosphorylated using CIP (A) or additionally de-N-glycosylated using 
PNGaseF (B) and further analyzed using 2D-gelelectrophoresis and anti-2B4 Western blotting. 
Representative results of at least three experiments are shown. 
Figure 20: 2B4 contains sialic acids and O-linked carbohydrates. Immunoprecipitated 2B4 
from NKL or NK92C1 cells was either dephosphorylated using CIP (A) or additionally desialylated 
using Neuraminidase (Neur) (B) or further de-O-glycosylated using O-Glycosidase (C). Treated 
proteins were separated using 2D-gelelectrophoresis and analyzed via anti-2B4 Western blotting. 
Representative results of at least two experiments are shown. 
RESULTS 
 
64 
 
4.2.4 The IgC2 domain has minor influence on glycosylation 
Human 2B4 consists of two Ig domains: the membrane distal V-type (IgV) and the 
proximal C2-type (IgC2) domain. Deletion of the C2-type domain could give information, 
how either of the domains contribute to the molecular weight of 2B4 by different 
amounts of glycosylation. 2B4 has an experimentally observed molecular weight of 
70 kDa and a calculated weight of 39 kDa. Experimental data illustrate, that deletion of 
the proximal domain led to a decrease of molecular weight from 70 kDa to 50 kDa and a 
significant shift of the pH values to a more basic range (Figure 21). Furthermore, a 
smear at 40 kDa as well as a vertical band on the cathode emerged. 
 
Ablation of the membrane proximal IgC2 domain resulted in a decrease of calculated 
molecular weight from 39 kDa to 32 kDa. Therefore, amino acids of the C2-type domain 
contribute to 7 kDa. The examined molecular weight of wildtype 2B4 is 70 kDa. Deletion 
of the IgC2 domain resulted in a remaining molecular weight of 50 kDa; a difference of 
20 kDa composed of 7 kDa protein and 13 kDa glycosylation. Glycosylation of wildtype 
2B4 leads to a mass addition of 31 kDa. As calculated yet, the glycosylation of the 
membrane proximal C2-type domain contributes to only 13 kDa mass addition. Hence, 
the glycosylation of the distal IgV domain constitutes the remaining 18 kDa and is 
therefore mainly responsible for the observed molecular weight of 2B4. 
Human 2B4 contains eight possible N-glycosylation sites. Three of them are found in the 
distal V-type Ig domain, four of them in the membrane proximal C2-type Ig domain and 
one near the transmembrane region. This is interesting, as the distal IgV domain seems 
to be mainly responsible for the alterations in molecular weight of 2B4, even if it contains 
less N-glycosylation sites than the membrane proximal IgC2 domain. 
 
4.2.5 The binding affinity of 2B4 to its ligand CD48 is affected by glycosylation 
The N-glycosylation sites within 2B4 are in close proximity to the binding site of its ligand 
CD48. According to the structure of murine 2B4 (Velikovsky et al., 2007) the N-linked 
carbohydrates may lie outside of the binding interface. However, they could still be 
involved in ligand binding due to their large size and highly negative charge. Additionally, 
also O-linked carbohydrates, for which no consensus motives are known, could have an 
impact on the function of the 2B4 receptor. To test how these carbohydrates could 
Figure 21: The IgC2 domain has minor influence 
in glycosylation. Immunoprecipitated 2B4 from HEK-
2B4 cells or HEK cells transfected with an IgC2 deletion 
mutant of 2B4 (dIgC2) were analyzed using 2D-
gelelectrophoresis and anti-2B4 Western blotting. 
Representative results of at least two experiments are 
shown. 
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influence the binding affinity of 2B4 to its ligand CD48 we expressed the extracellular Ig-
like domains of 2B4 linked to an isoleucine zipper (ILZ) motif as a recombinant soluble 
fusion protein in HEK cells. These 2B4-ILZ fusion proteins showed a glycosylation pattern 
similar to the 2B4 receptor found in stably transfected HEK cells and primary human NK 
cells (Figure 22A top). Also the difference between the apparent molecular weight of 
2B4-ILZ of about 55 kDa and the calculated molecular weight of 27 kDa can be explained 
by the addition of about 30 kDa due to glycosylation of the 2B4 fusion protein. 
Desialylation as well as de-O-glycosylation of the fusion protein shifted the pI to more 
alkaline pH and removal of N-linked carbohydrates resulted in a mass shift towards the 
calculated molecular weight (Figure 22A). This demonstrates that the glycosylation of the 
2B4-ILZ fusion protein is comparable to the 2B4 receptor expressed on NK cells. 
 
 
 
Figure 22: Binding of 2B4 to CD48 is affected by glycosylation. (A) 2B4-ILZ fusion proteins 
were left untreated or treated with Neuraminidase (Neur) and/or O-Glycosidase (O-Glycos) or 
PNGaseF as described in materials and methods. Successful deglycosylation was controlled by 2D-
gelelectrophoresis and anti-2B4 Western blotting. (B) Binding of PNGaseF treated 2B4-ILZ fusion 
protein to CD48 expressing HEK and HeLa cells (thick line) in comparison with untreated protein 
(thin line) and isotype control (grey area). (C) Concentration dependent binding of differentially 
treated fusion proteins to HeLa-CD48 cells. Neuraminidase (N, circles), Neuraminidase and O-
Glycosidase (N+G, square), untreated (untr, diamonds), and PNGaseF (P, triangles) treated 2B4-
ILZ fusion proteins were used at the indicated concentration in a FACS-based binding assay to 
HeLa-CD48 cells. (D) Binding of 60 ng/ml (grey bars) or 30 ng/ml (white bars) of Neuraminidase- 
(top) or Neuraminidase and O-Glycosidase- (bottom) treated 2B4-ILZ fusion proteins to HEK-
CD48, HeLa–CD48, NKL or NK92C1 cells. Data are presented in percent binding of treated versus 
untreated protein for at least four independent experiments. 
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We next asked the question how the removal of the different sugars from the 2B4-ILZ 
fusion protein would affect its binding to its ligand CD48. For this we used the fusion 
protein to stain HEK and HeLa cells stably transfected with CD48. Removal of N-linked 
carbohydrates by PNGase treatment almost abolished the specific binding of 2B4-ILZ to 
HEK-CD48 and HeLa-CD48 cells (Figure 22B,C). This demonstrates that N-linked sugars 
on 2B4 are essential for its binding to CD48. Interestingly, we observed a somewhat 
increased binding of 2B4-ILZ to HeLa-CD48 cells after removing sialic acid residues or 
additionally O-linked sugars (Figure 22C,D). This increase was consistently seen for 
many different CD48 expressing cells and suggests that sialic acid residues on 2B4 may 
have a negative impact for its binding to CD48. 
 
4.2.6 Inhibition of N-glycosylation with tunicamycin impairs cytotoxicity of NK 
cells 
To test if 2B4 glycosylation also has an impact on 2B4-mediated NK cell activation, we 
deglycosylated NK cells differentially to alter 2B4 bound carbohydrates. As PNGaseF 
failed to deglycosylate whole NK cells, we chose inhibitors to interfere with 
glycosyltransferases and thereby impair the posttranslational modification.  
It would be interesting, if the decreased binding of de-N-glycosylated 2B4-ILZ fusion 
proteins to CD48 expressing cells (Figure 23) could be repeated with NK cells, impaired 
in N-glycosylation. To interfere with N-glycosylation on NK cells, we chose tunicamycin 
which abrogates the transfer of N-acetylglucosamine-1-phosphate (GlcNAc-1-P) from 
UDP-GlcNAc to dolichol-P by blocking the GlcNAc phosphotransferase. Tunicamycin 
treatment of NK cells for 24 h led to a reduction of viability of both NK cell lines tested 
when compared to control treated cells, as seen by a shift in the forward and side scatter 
(FSC and SSC) population (Figure 23A, left panel). To test if tunicamycin impairs protein 
expression itself, we controlled the surface expression of the receptors 2B4 and CD48 via 
flow cytometry. As depicted in Figure 23A, right panel, 2B4 as well as CD48 expression 
were slightly diminished. Nevertheless, the ablation of sialic acids as result of de-N-
glycosylation decreased even more, indicating a greater reduction of surface 
glycosylation than receptor downmodulation. Hence, as receptor expression and viability 
seemed to be only slightly impaired by tunicamycin, we tested their ability to lyse Mock- 
or CD48- transfected HeLa cells as targets for different NK cells. The presence of CD48 
clearly enhanced the lysis of HeLa cells by the NK cell lines NKL and NK92C1, 
demonstrating the specific NK cell activation through 2B4 (Figure 23B). In contrast, the 
killing activity of tunicamycin treated NKL as well as NK92C1 cells against CD48 
expressing target cells was significantly reduced back to the level of control target cells. 
To analyze, if the observed effects could be traced back to de-N-glycosylation, 2B4 
immunoprecipitates of NKL and NK92C1 cells were examined via Western blotting (Figure 
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23C). Interestingly, only NK92C1 cells revealed a reduction in molecular weight up to 
39 kDa. NKL cells did not depict any reduction in molecular weight of 2B4. Herewith, only 
a slight decrease in band intensity at 70 kDa could be observed. Thus, the reduction of 
killing capacity of tunicamycin treated NK seems to be mainly caused by the increased 
apoptosis of these cells after tunicamycin treatment and not by efficient de-N-
glycosylation. 
 
 
 
 
 
 
 
 
 
Figure 23: Tunicamycin inhibits NK cell cytotoxicity. NK cells were treated with DMSO as 
control or tunicamycin for 12 h at 37 °C. (A) Control (Cont) or tunicamycin (Tm) treated NKL 
cells were analyzed via flow cytometry. Left panel represent the forward / sideward scatter dot 
blot. Viable cells were gated and percentage values are shown. The graph on the right shows 
the surface staining of indicated receptors. Sialic acids (SA) were stained using rhSiglec7-Fc 
Chimera. (B) Treated NK cells were used as effector cells in a 4 h chromium release assay 
against HeLa-CD48 or HeLa-Mock cells. One representative experiment of three is shown. (C) 
Treated NK cells were lysed and immunoprecipitated 2B4 was analyzed using SDS-PAGE 
followed by anti-2B4 Western blotting. 
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4.2.7 Inhibition of O-glycosylation as well as removal of sialic acids increase 
the killing activity of NK cells 
As tunicamycin seemed to bear further effects than inhibition of N-glycosylation, we 
turned our attention to sialic acids and O-glycosylation.  
Successful removal of sialic acid from the surface of NK cells was performed by 
Neuraminidase treatment. The analysis of the immunoprecipitated 2B4 receptor from the 
treated cells by 2D-gelelectrophoresis followed by Western blotting showed a clear shift 
towards basic pH, demonstrating the effectiveness of the treatment (Figure 24A). 
Compared to control-treated NK cells, Neuraminidase treated NK cells showed enhanced 
killing capacity against CD48 expressing target cells (Figure 24B). While the extent of the 
enhanced lysis varied between experiments, we consistently observed better 2B4-
mediated killing by Neuraminidase treated NK cells. 
 
 
 
 
 
 
 
Figure 24: Desialylation of NK cells results in increased 2B4-mediated target cell lysis. NK 
cells were treated with DMSO as control (DMSO) or Neuraminidase for 2 h at 37 °C (Neur). (A) 
Treated NK cells were lysed and immunoprecipitated 2B4 was analyzed using 2D-gelelectrophoresis 
followed by anti-2B4 Western blotting. (B) Treated NK cells were used as effector cells in a 4 h 
chromium release assay against HeLa-CD48 or HeLa-Mock cells. One representative experiment of 
at least four is shown. 
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To interfere with O-glycosylation we cultured the NK cells with the inhibitor BADG 
(benzyl-α-N-GalNAc). BADG competes with endogenous GalNAc-O-Ser/Thr for 
galactosyltransferase and therefore prevents the elongation of O-glycosyl chains. 
Analysis of 2B4 from the treated cells showed a loss of negative charge as well as slight 
decrease in molecular mass due to loss of O-glycosidic bound carbohydrates (Figure 
25A). As seen before for desialylated NK cells the BADG treated effector cells showed 
enhanced killing activity against CD48 expressing target cells, too (Figure 25B). 
 
 
These data demonstrate that 2B4-specific NK cell activation can be enhanced by removal 
of sialic acid from the surface of NK cells or the inhibition of O-linked glycosylation and 
correlates nicely with our observation that the removal of these sugars can enhance the 
ligand binding activity of 2B4. 
 
 
 
Figure 25: De-O-glycosylation of NK cells results in increased 2B4-mediated target cell 
lysis. NK cells were cultured in the presence of DMSO as control (DMSO) or the O-glycosylation 
inhibitor BADG for 48 h (BADG). (A) Treated NK cells were lysed and immunoprecipitated 2B4 
was analyzed using 2D-gelelectrophoresis followed by anti-2B4 Western blotting. (B) Treated NK 
cells were then used as effector cells in a 4 h chromium release assay against HeLa-CD48 or 
HeLa-Mock cells. One representative experiment of at least four is shown. 
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5 DISCUSSION 
5.1 Membrane microdomains surrounding NK cell receptors 
5.1.1 Establishing of a bead-based isolation protocol to analyze the natural 
membrane microdomains surrounding NK cell receptors  
NK cells regulate their activity by a balance of positive and negative signals upon 
engagement of various activating and inhibitory receptors. It has been shown that 
activating receptors are recruited into defined membrane microdomains termed “lipid 
rafts” after stimulation, whereas inhibitory receptors are excluded from these regions. 
This localization plays an important role in signal transduction, as disruption of lipid rafts 
completely blocks the target cell lysis (Watzl et al., 2003). The exact mechanisms, the 
interplay between these receptors as well as the involved signaling molecules are not 
known.  
Here we used a new approach to isolate membrane fragments surrounding NK cell 
receptors without destroying their natural composition as it has been criticized for the 
cold non-ionic detergent lysis. The method used here is based on the stimulation of NK 
cells with antibody coated magnetic beads. Cells were disrupted mechanically via 
nitrogen cavitation. Receptors and adjacent membrane fragments, as well as parts of the 
cytoplasm were immunoisolated by separation of the magnetic beads. The protein 
composition was analyzed using biochemical methods like Western blotting and 2D-
gelelectrophoresis, as well as mass spectrometry for protein identification. Varying the 
setup with respect to stimulation time or engagement of different receptors enables us to 
gain a deeper insight into NK cell regulation.  
This technique has already been established for the enrichment of activated TCR (Harder 
et al., 2000). However, in contrast to T cells, NK cells exhibit the advantage to form 
separate clusters for activating and inhibitory synapses - the so called SMAC and SMIC 
(Orange et al., 2003; Vyas et al., 2002). So, two contrary operating receptor types as 
well as their interplay may be compared instead of an activating system in comparison to 
the surrounding cell membrane as it was shown for T cells (Harder et al., 2001).  
Nevertheless, by transferring the system established for T cells we first confirmed that it 
is suitable for NK cells. Thereby we could show that anti-2B4 coated beads are able to 
stimulate NKL cells, since receptor phosphorylation as well as IFN-γ release (Figure 11, 
Figure 12) could be observed. By using a bead:cell ratio of 0.5 we ensure specific binding 
of beads to cells, where only the engaged receptors were phosphorylated and the 
remaining receptors stay untouched. This finding is very essential, as it has been shown 
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that NK cells are able to distinguish between inhibitory and activating signals occurring at 
two different contact zones (Eriksson et al., 1999a).  
It has recently been shown, that synergistic activation of NK cells via NKG2D and 2B4 is 
Vav1 dependent (Kim et al., 2010). Whereas these experiments were performed using 
antibody crosslinking, our results demonstrated that synergistic coactivation can also be 
performed using antibody coated beads (Figure 12B). Our results further confirm that 
costimulation with antibody coated magnetic beads results in proper IFN-γ release 
(Figure 12C,D) a characteristic feature of NK cell activation. Hence, it would be very 
interesting to use nitrogen cavitation to confirm the results. If the findings could be 
validated, analysis of membrane microdomains obtained after mechanical disruption of 
cells could give further insights in how NK cell receptors regulate the synergistical 
outcome of costimulation.  
Activation of NK cells results in proceeding signaling cascades, mainly due to 
phosphorylation events. We were able to confirm this as stimulation for longer periods 
results in enhanced receptor phosphorylation (Figure 12A) as well as in the appearance 
of additional phosphoproteins (Figure 14). This could be a hint for the proceeding 
signaling cascade. As the number, as well as the appearance of molecules did not change 
after different stimulation time, it would be interesting to identify the proteins which were 
further phosphorylated after longer stimulation period. Therefore, phosphorylated 
proteins of immunoisolates could be post-immunoprecipitated, separated via 1D- or 2D-
gelelectrophoresis and further characterized using mass spectrometry. Another possibility 
would be, to compare samples after stimulation using different activating receptors. As 
inhibition mostly results in the activation of phosphatases (Tomasello et al., 2000; Vely 
and Vivier, 2005) instead of recruitment of kinases, as has been shown for activating 
receptors, one might expect that inhibitory samples do show less phosphorylated 
molecules. However, as this has not been investigated until now, it would be interesting, 
if the isolation of membrane microdomains using nitrogen cavitation would confirm this. 
By doing so, further insights into proceeding signaling cascades would help us to 
understand the very first steps occurring after NK cell receptor engagement and maybe 
help us to identify phosphorylated proteins involved in NK cell receptor signaling not 
identified up to now.  
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5.1.2 Inhibition versus activation – Outcome of differential NK cell receptor 
engagement 
As we suggest that proteins occurring after costimulation differ only marginally, it would 
be easier to begin with a simplified experimental setup. Activating receptors are recruited 
into lipid rafts, whereas inhibitory receptors stay outside and are also able to block raft 
recruitment of activating receptors (Tomasello et al., 2000; Watzl et al., 2003; Watzl et 
al., 2000). Therefore, the proteins that accumulate at the SMAC should differ highly from 
those at the SMIC and should easily be visualized via 2D-gelelectrophoresis. As we could 
confirm activation of NK cells after 2B4 stimulation and NK cell inhibition after NKG2A 
engagement (Figure 12) we chose these receptors to analyze membrane microdomains 
surrounding both receptor types. As the system has not been established for NK cells, we 
first concentrated on single receptor engagement. Future experiments should be 
performed to analyze, which consequences on the level of signaling molecules 
simultaneous engagement of antagonistic receptors could have.  
As seen already for the silver stained samples separated via 2D-gelelectrophoresis 
(Figure 15), the immunoisolated proteins seemed to be to about 99 % identical. 
Nevertheless, by combining the method of immunoisolation with 2D-DIGE we expected to 
be able of getting clear differences between inhibitory and activating samples as 
background bound proteins would not result in significant differences. However, only few 
spots appear to be significantly different (t<0.05) whereas the average ratio between the 
different samples was sometimes only marginal. Furthermore, only 14 proteins were 
considered to be functionally relevant and were sorted according to this feature in Table 
2. The complete list is attached at the end of the thesis.  
One of the identified, relevant proteins is ezrin (EZRI_HUMAN). As a member of the ERM 
family (ezrin, radixin and moesin), it contains three domains, an N-terminal globular 
domain, an extended alpha-helical domain and a charged C-terminal domain (Tsukita 
and Yonemura, 1997). ERM proteins crosslink actin filaments with certain 
transmembrane proteins. Ezrin has been shown to associate with CD43, a 
transmembrane receptor important for ligand-receptor complexes involved in T cell 
activation (Bretscher et al., 1997; Tsukita and Yonemura, 1999). Ezrin was either 
excluded from (Allenspach et al., 2001) or clustered at the peripheral edges of (Roumier 
et al., 2001) the activating T cell immunological synapse. CD43 may support adhesion as 
it interacts e.g. with the intercellular adhesion molecule-1 (ICAM-1).  
In our case, ezrin has been found to greater extent in the 2B4 sample (average ratio 
2B4 : NKG2A = 1.38). As mentioned before, it has been shown that the activating 
receptor 2B4 is recruited into so called DRM and that this is an actin-dependent process 
(Watzl et al., 2003). Inhibitory receptors, in contrast, are excluded from these 
specialized membrane domains. Interestingly, McCann et al. demonstrated that ezrin and 
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CD43 were excluded from the NK cell inhibitory synapse (SMIC) but not from the 
activating synapse (SMAC) (McCann et al., 2003). They proposed that the presence of 
CD43 in the activating NK cell synapse may be necessary to maintain effector/target 
contact during effector functions (Davis et al., 1999). This is further supported by our 
finding that ezrin is probably an important molecule for 2B4 mediated signaling. Our 
results lead to the suggestion that ezrin is involved in SMAC formation and that it is 
recruited within five minutes to the NK cell activating synapse. 
A second important protein identified by mass spectrometry, is RhoGDI2 (Rho GDP 
dissociation inhibitor beta) (ARHGDIB). Rho family proteins like Rho, Rac and Cdc42 are 
involved in cytoskeletal rearrangements and are essential in processes like cell motility, 
adhesion and phagocytosis (Hall, 1990; Ridley and Hall, 1992a; Ridley et al., 1992b; 
Takai et al., 1995; Zigmond, 1999). They are mostly found near the plasma membrane, 
where they directly can regulate morphological changes. The Rho family belongs to the 
small GTP-binding protein superfamily. Active forms (GTP-Rho) and inactive forms (GDP-
Rho) are interconverted with help of guanine nucleotide exchange factors (GEFs) and 
GTPase-activating proteins (GAPs). RhoGDI has been identified as GEF, which catalyzes 
the dissociation of GTP from Rho proteins and prevents formation of the GDP-bound 
state, thereby keeping Rho proteins in an inactive state. First, we were surprised by the 
identification of RhoGDI2 as it also is primarily associated with the activating membrane 
microdomain. Does the finding of RhoGDI imply a termination of the signaling cascade, 
as soon as five minutes after stimulation? Furthermore, how would this explain the 
contrary finding of ezrin? Interestingly, Hirao et al. and Takahashi et al. demonstrated 
that the (ezrin, radixin and moesin) ERM family member moesin tightly associates in a 
CD44-complex with the RhoGDI in BHK (baby hamster kidney) cells (Hirao et al., 1996; 
Takahashi et al., 1997). RhoGDI has been shown to bind to the amino-terminal domain 
of ERM proteins. The ERM family members have been shown to appear in a closed 
conformation due to intramolecular association between the amino-terminal and carboxy-
terminal association domain (termed N-ERMAD and C-ERMAD, respectively). This so-
called “dormant” form is not able to bind e.g. F-actin or RhoGDI. Upon activation, the 
binding sites become unmasked and allow linkage of e.g. transmembrane receptors with 
the cytoskeleton. The closed “dormant” form inhibits the binding of RhoGDI to ezrin. 
Therefore, RhoGDI is able to bind Rho family members, inducing their inactive state. 
Activation of ERM proteins can cause the dissociation of RhoGDI from Rho and thus lead 
to an activation of the small GTP-binding proteins (Takahashi et al., 1997). One target of 
Rho family proteins is the Rho-kinase which, in turn, can now phosphorylate ERM 
proteins, leading to their activation state maintenance (Mackay et al., 1997; Matsui et 
al., 1998). Hence, rather than being a negative factor for cytoskeletal rearrangement, 
binding of RhoGDI by ERM proteins may be a fundamental requirement for the activation 
of Rho signaling pathways, by promoting GTP-Rho formation. It would be very interesting 
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to see, if the signaling pathway of 2B4 could be linked with cytoskeletal rearrangement 
pathways involving ezrin and RhoGDI. A functional association between those molecules 
would increase our knowledge about the regulation of activating NK cell receptors.  
 
Like ezrin, calpain is involved in cytoskeletal remodeling and signal transduction. Our 
mass spectrometry analysis identifies the small subunit 1 of calpain (CPNS1_HUMAN) as 
another signal molecule, mainly appearing in the activating sample of our experimental 
setup (Av. Ratio 2B4:NKG2A=1.27). As it has been reported that calpain translocates to 
the plasma membrane upon calcium binding (Gil-Parrado et al., 2003), it would fit to our 
model, too. Calcium is an important mediator of adhesion and cytoplasmic processes. 
The ion is not only needed by cell adhesion molecules e.g. integrins in order to maintain 
their adhesiveness towards the extracellular matrix. Also, many intracellular signaling 
cascades, mainly including cytoskeletal organization, would be interrupted in the absence 
of Ca2+. The ubiquitously expressed calpain protein family binds Ca2+, too. They consist 
of two subunits: a large catalytic and a small regulatory subunit. Upon calcium binding, 
calpains are able to function as cysteine protease and thereby predominantly cleave 
FERM (Protein 4.1/ezrin/radixin/moesin) domains. Is the identification of the CPNS1 
protein in contrast to our previously reported results or does it fit? As demonstrated 
previously, calpains are necessary for cell spreading and migration as they regulate actin 
remodeling (Potter et al., 1998). ERM proteins link transmembrane proteins to the 
cytoskeleton and thereby stabilize a tight association of the cell membrane with the 
intracellular compartment. The release of this connection is important to allow the 
rearrangement of cell membrane molecules as well as the flattening of the cell towards 
the surface touched, in order to get as much contact as possible (Dewitt and Hallett, 
2007). Interestingly, ezrin seems to be more sensitive to calpain mediated cleavage than 
e.g. moesin, another member of the ERM family (Shcherbina et al., 1999). Hence, the 
identification of the small subunit of calpain could denote a mechanism by which the NK 
cell rearranges its cytoskeleton to form closer contact towards its target cell. Shenoy et 
al. suggest a negative influence of calpain-mediated proteolysis to the NK cell mediated 
target cell lysis (Shenoy and Brahmi, 1991). They could increase NK cell activity against 
K562 target cells by using two different calpain inhibitors. As protein kinase C (PKC) 
inhibitors circumvent this enhancement, they conclude a direct involvement of the Ca2+ 
binding protein in signaling pathways rather than in cytoskeleton rearrangement. As we 
analyzed partial membrane areas and adjacent cytoplasmic regions of receptor 
stimulated NK cells, it could be possible that calpain fulfills two different functions due to 
its localization and also due to its time dependent activation. Within our experimental 
setup, we stimulate NK cells only few minutes. Therefore, a cytoskeletal rearrangement 
to tighten the contact between NK cell and bead may be most likely. The functionality of 
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calpain in the activation of NK cells remains open and needs to be further examined. An 
overview of possible interactions is given in Figure 26. 
 
 
Another protein identified by mass spectrometry is Grb2 (Growth factor receptor-bound 
protein 2 isoform 1) (GRB2_HUMAN). It consists of one Src homology 2 (SH2) and two 
SH3 domains. SH2 domains recognize phosphorylated tyrosines, whereas SH3 domains 
bind to proline-rich regions. As it functions as an adaptor molecule, it is involved in many 
signaling pathways e.g. MAPK, Jak-STAT or chemokine signaling pathway, but it also 
plays an important role in TCR or BCR mediated activation of lymphocytes. Recently, 
Upshaw et al. showed that Grb2 associated to Vav1 binds to the NKG2D-DAP10 complex, 
leading to the activation of downstream signaling and finally to cytotoxicity (Upshaw et 
al., 2006). This is a quite interesting fact, as NKG2D is an activating receptor and we 
found Grb2 mainly in the inhibitory NKG2A sample. Interestingly, Schleinitz et al. found 
that the activating receptors 2B4 and CD2 are recruited into KIR mediated inhibitory NK 
cell synapses (Schleinitz et al., 2008). Furthermore, they could show that CD2 is 
clustered at inhibitory NKIS more frequently and more rapidly than at activating 
synapses. They concluded that inhibitory KIRs prevent 2B4 and CD2 signaling by 
accumulating these activating receptors in an actin independent manner at the inhibitory 
NK cell synapse. Anyhow, if this is also true in our case, the appearance of Grb2 in the 
inhibitory sample cannot be explained as inhibitory receptors would block the recruitment 
of adaptor molecules. In summary, we currently cannot explain this finding. 
It will be interesting to see whether the proteins identified by mass spectrometry are 
involved in corresponding signaling pathways. The results obtained here should thereby 
be confirmed by Western blotting. Thereby primary cells could be tested, too, as smaller 
Figure 26: Model of 2B4 mediated signaling pathways due to our mass spectrometry 
results. Engagement of 2B4 leads to close proximity of the NK cell receptor with CD44 or CD43. 
Both were shown to interact with the ERM family molecule ezrin in its dormant form. Activation 
leads to the open conformation of ezrin and binding of RhoGDI and F-actin to ezrin. Consequently, 
from RhoGDI released Rho-GDP is able to exchange GDP to GTP and thus converts into its active 
state. This subsequently leads to activatory signaling. On the other hand, the activated form of 
ezrin binds F-actin as well and thereby leads to the formation or maintenance of a supramolecular 
activation cluster (SMAC). Calpain disrupts the tight association of ezrin and actin by cleaving the 
ERM molecule, thereby enabling the rearrangement of the cytoskeleton in order to form closer 
contacts with the target cell. Correlation between 2B4 and CD43 or CD44 as well as the interplay 
between receptors and cytoplasmic molecules remains to be confirmed. 
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amounts of proteins are sufficient. If the results could be verified, knock down 
experiments using siRNA may give a hint for the necessity of the identified proteins in NK 
cell signaling. 
 
5.1.3 Immunoisolation of transmembrane receptors - general aspects  
The finding of Grb2 depicts the limitations of the mechanical disruption method. As large 
numbers of cells have to be used to obtain adequate protein amounts for 2D-DIGE 
analysis, background bound proteins cannot be avoided. As has been shown in Figure 13, 
we cannot get rid of the characteristic non-lipid raft marker CD45, even by reducing the 
size of isolated fragements. The protocol was adapted from Harder and Kuhn (Harder et 
al., 2000) where the same amount of Jurkat T cells were stimulated with anti-CD3 coated 
magnetic beads and membrane fragments surrounding TCR could successfully be isolated 
and analyzed. It cannot be ruled out that T cells have another expression profile for the 
TCR than NK cells have for activating receptors. This ratio of TCR in relation to T cell 
surface could account for more precise isolation of membrane areas surrounding those 
receptors. As we monitored NKL recognition of beads by microscopy analysis (data not 
shown) we could not recognize any uncommon “behavior” of cells. The contacts were 
formed within seconds after beads recognition. On the other hand, by analyzing 
immunoisolates of pre-surface labeled NK cells, we recognized the occurrence of larger 
membrane areas in correlation with longer stimulation periods (data not shown). Those 
membrane areas were primarily not due to enlarged attachment of cells to beads as they 
occour outside the contact area. Maybe the pressure release of the nitrogen cavitation 
bomb causes “wrapping” of the cells around the beads which may lead to high 
background level of uninvolved proteins. Using a larger buffer:cell ratio could probably 
help to circumvent this negative side-effect. Furthermore, we plan to treat 
immunoisolates still bound to beads shortly with different detergents to remove 
uninvolved cell membrane. In fact, we wanted to avoid the use of detergents, as e.g. 
Triton X-100 induces the clustering of lo domains thereby leading to false positive 
conclusions. However, as we intend to use detergent after disruption of cells, the 
membrane surface was already shrunk to the contact area towards the beads which 
probably evades any raft clustering. But as weak lipid-protein interaction may also get 
lost by the use of detergent, the benefit of mechanical cell disruption must not be 
neglected.  Another possibility to increase the yield of immunoisolates is the use of a 
non-cell-permeable crosslinker. This was already performed by Hartgroves et al. 
(Hartgroves et al., 2003). The advantage would be that antibody chains would be 
coupled covalently to the beads. However, crosslinking also bears the disadvantage that 
transmembrane proteins cannot be dissolved in lysis buffer anymore. Anyhow, as 2D-
gelelectrophoresis harbors the difficulty to separate highly hydrophobic proteins, the loss 
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of membrane proteins due to crosslinking might not be noticed, whereas a more specific 
isolation of intracellular proteins could be achieved. Nevertheless, the organization of 
lipid rafts, the interplay between receptors and the association of yet undefined receptors 
is highly attractive and should be investigated further. The problem of insolubility of 
membrane proteins could be circumvented by using new sorts of detergents. The 
zwitterionic detergent ASB-14 is sufficient in dissolving 2B4 and therefore may be 
attractive for analyzing hydrophobic proteins. To bypass the difficulty of insolubility of 
highly hydrophobic proteins completely, separating via 1D-gelelectrophoresis might be an 
alternative method. However, as this technique is unsuited to achieve a resolution as 
high as the combined separation via pH and molecular weight, differences between 
samples might not be detected. Running the samples in two different lanes followed by 
mass spectrometry is almost the only way to detect differences at present. The recently 
described SILAC (stable isotope labeling by amino acids in cell culture) technique 
promises the relative quantitation of differences in protein abundance. Here, one cell 
population is fed with growth medium containing unaltered amino acids (e.g. the later 
2B4 stimulated sample), whereas the second population (e.g. the later NKG2A stimulated 
sample) is fed with medium containing amino acids labeled with stable heavy isotops. 
Samples would be prepared using nitrogen cavitation as previously described in this 
thesis, combined and analyzed at once by mass spectrometry, which is able to 
distinguish between the differentially labeled proteins. Furthermore, the peak ratio 
reflects the abundance of peptides. Thus, SILAC provides the huge advantage to get 
precise information about quantitative protein levels in two differently labeled samples. 
The 2D-DIGE technique requires large amounts of proteins and therefore rules out the 
analysis of primary cells and comparison of different donors. SILAC followed by mass 
spectrometry is highly sensitive and therefore could allow the analysis of primary cells, 
too.  
In addition to proteins surrounding NK cell receptors, the analysis of lipids in proximity to 
transmembrane proteins could give further information about the organization of 
specialized membrane areas. It has been proposed that specialized membrane 
assemblies are stabilized by lipid-lipid and lipid-protein interactions. Therefore, even 
lipids seem to play an important role in maintaining the functional domains for receptor 
signal transduction. Simons et al. as well as Zech et al. analyzed immunoisolates of TCRs 
via mass spectrometry and showed that certain lipids are segregated at the receptor 
activation domain (Simons et al., 2004; Zech et al., 2009). It would be rather 
interesting, if immunoisolates of activating and inhibitory NK cell receptors differ in their 
lipid composition and if also a discrimination between the lipid composition of different 
activating receptors is possible.  
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The here established bead-based immunoisolation method is a powerful detergent-free 
technique to provide deeper insights into the natural composition of membrane 
microdomains surrounding NK cell receptors. Knowledge gained about structure and 
composition of membrane domains could help us to examine and understand functional 
consequences of the complexity of proteins and lipids in biological membranes.  
 
5.2 Glycosylation of 2B4 and its effect in ligand binding and function 
 
Glycosylation is an important post-translational modification of membrane proteins and 
crucial for proper cell function. Many cellular processes like cell adhesion, signal 
transduction and receptor activation involve glycosylated proteins. In recent years, it 
became clear that mutations in biosynthetic pathways of glycans may be lethal or lead to 
severe defects (Freeze et al., 2001). These mutations frequently concern the formation 
of extracellular matrix (ECM) molecules or neuronal disorders. Thereby the organism fails 
to assemble essential molecular networks for trafficking and adherence. Nonetheless, 
receptor glycosylation also is highly regulated. Improper glycosylation affects protein 
folding and often results in protein retention in the ER or Golgi complexes and finally 
leads to its degradation. Therefore, plasma membrane proteins fail to reach the surface 
and ECM proteins will not be exocytosed, as well. Additionally, wrong glycosidic bonds or 
the attachment of incorrect carbohydrates alters the confirmation of the sugar tree 
resulting in masking or exposure of improper protein or glycosidic components. As sugar 
molecules, especially sialic acids, serve as recognition sites for receptors, improper 
glycosylation leads to a failure of interaction.  
2B4 is an important and well-characterized activating receptor for NK cell activation. 
Among others its engagement results in IFN-γ production, a main characteristic of NK cell 
responses. Though 2B4 is characterized better than any other NK cell receptor, less is 
known about its extracellular part and its influence in receptor engagement. It is known 
that 2B4 contains several N-glycosylaton sites (Tangye et al., 1999) but it has not been 
studied until now, if those influence the interaction with its ligand CD48. 
Our data confirm the expression of 2B4 as a 70 kDa protein in all cell populations (Figure 
17A) but also reveal a heterogeneous modification because 2B4 is distributed broadly 
over the pH gradient. Interestingly, the receptors of NKL, HEK-2B4 cells as well as 
primary NK cells exhibit mainly neutral pH, whereas the NK cell line NK92C1 represents a 
more basic receptor population. This could not be traced back to different 
phosphorylation of the cytosolic part of the SRR as dephosphorylation of 2B4 as well as 
analyzing the ITSM mutant and thereby phosphorylation incompetent form of 2B4 
(Y1,2,3,4F) did not result in the ablation of multiple spots (Figure 17B + Figure 18). 
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Anyhow, a slight shift towards basic pH as well as a faint phosphotyrosine signal in 
untreated samples could be observed for NK cells (data not shown), which was not true 
for HEK-2B4 cells (Figure 18). CD48, the ligand of 2B4, is expressed on all NK cells, 
which led to the assumption that the SRR is slightly but constantly stimulated. This 
engagement may occur by interaction with other cells (trans) as well as on the same cell 
surface (cis). As HEK-2B4 cells did not express CD48 per se, a receptor-ligand interaction 
and thereby induced receptor background phosphorylation is impossible. Because of this, 
2B4 on NK cells but not on transfected HEK cells receives a continuous, slight stimulus 
via CD48, leading to background phosphorylation of 2B4. Nevertheless, this shift seems 
to be of only minor importance and might as well not be responsible for the appearance 
of miscellaneous spots. 
PNGaseF treatment of 2B4 results in a mass reduction of 30 kDa, as well as in a now 
comparable spot pattern between the cell populations which shifted to more basic pH 
after treatment. This suggests that N-linked carbohydrates on 2B4 differ between 
NK92C1 and the other examined NK cells. It further shows that N-linked sugars account 
for the 30 kDa difference between calculated and apparent molecular weight of the 2B4 
receptor. Zielinska et al. have shown that N-glycosylation is not restricted to the N-!P-
[S/T] sequence motif (where !P is any amino acid except proline) or the uncommon N-X-
C motif but can also be found on yet unknown positions (Zielinska et al., 2010). 
Furthermore, only 30 % of all available motifs within a protein are glycosylated with 
some of them showing only incomplete glycosylation (Mellquist et al., 1998). This results 
in a heterogeneous population of differentially glycosylated proteins as we have found for 
the 2B4 receptor. 
The 2B4 receptor still migrated as distinct spots covering a broad pH range after the 
removal of N-glycans. This suggested the presence of additional sugar moieties that are 
highly charged and of small size. Using Neuraminidase to desialylate immunoprecipitated 
2B4 we could show, that all 2B4 molecules migrate to one distinct point and thereby 
verify the presence of sialic acids. These small monosaccharides exhibit a nine-carbon 
backbone and are always negatively charged due to their C1 carboxylate group. The 
common human sugar is the N-acetylneuraminic acid (Neu5Ac), containing an N-acetyl 
group at the 5-carbon position. But other modifications like de-N-acetylation or 
substitutions at the other carbons are known. This variability could further influence the 
charge of sialic acids and thereby influence the pI of the glycoprotein. It would be 
interesting if differences in pI of 2B4 from NKL and NK92C1 cells could be contributed to 
different numbers or different modifications of sialic acids. Therefore, various 
combinations of treatments with sialidases, 9-O-acetylesterases and mild periodate 
oxidation could be used to elucidate sialic acid moieties of 2B4 expressed by different cell 
populations. 
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The differential glycosylation of 2B4 could be attributed to sialic acid residues on both N- 
and O-linked sugars as removal of sialic acids created a population of 2B4 molecules 
migrating at one distinct pI. Considering the bioinformatic tools of the CBS prediction 
service databank (www.cbs.dtu.dk/services/) the sequence of 2B4 does not reveal any 
O-glycosylation site. However, there is no clear consensus sequence for O-glycosylation 
sites. As we still observed distinct spots after removal of N-glycosylation we suggest that 
2B4 is also modified by O-linked sugars. The enzymatic removal of O-glycosidic bound 
carbohydrates requires first a removal of sialic acids, making a specific analysis of O-
linked sugars difficult. As O-glycans are less branched and therefore less in molecular 
weight, a mass reduction may be difficult to visualize. We observed an increase in 
molecular weight of 2B4 after removal of O-glycosidic bound carbohydrates compared to 
the removal of sialic acids alone. This rather surprising result might be explained by 
peptide dimerisation due to diminished repulsion after removal of O-linked sugars. 
We further analyzed the influence of the membrane proximal C2-type (IgC2) domain on 
the molecular weight of 2B4. Using a mutant with an ablation of IgC2 domain reveals 
that the distal V-type Ig domain is mainly responsible for the alterations in molecular 
weight of 2B4. This is highly interesting as the membrane proximal IgC2 domain contains 
more N-glycosylation sites in comparison with the distal IgV domain. As mentioned 
before, it has been shown (Zielinska et al., 2010) that N-glycosylation is not restricted to 
the common known N-!P-[S/T] sequence. It could be possible that the membrane distal 
domain contains more N-glycosidic bound carbohydrates as shown by sequence analysis. 
But it is also feasible that the V-type domain contains more branched carbohydrate trees 
and thereby accounts more to molecular mass as the membrane proximal domain. The 
observation that the distal domain is mainly responsible for the molecular weight is really 
unexpected, as glycosidic bonds may impair the binding of 2B4 to its ligand CD48. It has 
been shown that the N-terminal domain is responsible for the receptor-ligand interaction 
(Velikovsky et al., 2007). Hence, glycosylation of the distal domain may rather contribute 
to receptor ligand interaction than abrogating it.  
The structural information available today about the interaction between 2B4 and CD48 
did not implicate glycosylation to be important for this binding. Furthermore, it has been 
shown that binding by the 2B4 related receptor CD2 to its ligand CD58 is independent of 
glycosylation (Davis et al., 1995). Anyhow, CD2 contains only one potential N-
glycosylation site in its membrane distal IgV domain which lies on the opposite site of the 
contact area with CD58 (Davis et al., 1995). Contrary to this, two of three N-
glycosylation sites of the membrane distal IgV domain of 2B4 are in close proximity to 
the putative CD48 binding site (Velikovsky et al., 2007) and could have major influence 
in ligand binding.  
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Based on the CD2-CD58 interaction Mathew et al. showed that Lys68 and Glu70 of the 
human 2B4 IgV domain were necessary for ligand binding (Mathew et al., 2005)[29]. 
However, in our hands these mutations were not sufficient to abolish ligand binding. Only 
a 2B4 triple mutant K54A/H65A/T110A, based on the structure of the murine 2B4-CD48 
complex (Velikovsky et al., 2007), completely abolished binding to CD48 (Claus, Watzl, 
unpublished results). These results show that the human 2B4-CD48 interaction is similar 
to the murine receptor and that glycosylation may play an important role in ligand 
recognition and binding.  
Our data demonstrate that N-glycosylation of 2B4 is essential for this interaction, as 
removal of these sugars from the 2B4 fusion protein almost completely prevented its 
binding to CD48 expressing cells (Figure 22 B,C). We are aware that de-N-glycosylation 
might also impair the structure of the isolated 2B4-ILZ fusion protein used and further 
controls are needed. We plan to analyze the correct folding of de-N-glycosylated 2B4-ILZ 
via correct binding of the anti-2B4 antibody (C1.7) in flow cytometry assays and also via 
ProteoStat Protein Aggregation Assay (Enzo, Germany), which enables the detection of 
aggregated proteins due to their characteristic cross-beta spine quaternary structure. 
Furthermore, secondary structure of 2B4 might be controlled via circular dichroism, a 
biophysical method able to distinguish between beta-sheet and alpha-helix conformation. 
The use and modification of recombinant 2B4-ILZ fusion proteins provided first insights 
into the influence of different carbohydrates in receptor-ligand interaction. Furthermore, 
it would be interesting to modify the glycosylation structure of 2B4-ILZ proteins with 
respect to only minor changes in glycosidic bonds. Cell lines with different defects in 
glycosylation are a useful tool to alter protein glycosylation in a defined way. Chinese 
hamster ovary (CHO) and baby hamster kidney (BHK) lack a functional α(2,6) 
sialyltransferase and make exclusively α(2,3)-linked Neu5Ac (Hossler et al., 2009; 
Jenkins, 1995). Other cell lines such as HEK cells (Durocher and Butler, 2009), human 
retinal cells (PERC.6) (Jones et al., 2003; Petricciani and Sheets, 2008; Wurm, 2004) 
and mouse myeloma (NS0) (Gramer and Goochee, 1994) are also feasible to study the 
outcome of different glycosidic bound carbohydrates due to differences in glycosylation. 
Analyzing the binding of 2B4-ILZ expressed in these cells towards CD48 expressing cells 
could give information which carbohydrates are involved in or impair the ligand 
recognition. Furthermore, analysis of stepwise and combined mutations of the N-
glycosylation sites of 2B4 would help to define the exact position of glycans which 
enhance or diminish receptor-ligand interaction. Use of different lectins combined with 
Western blotting could further help us to identify carbohydrates bound to 2B4. This 
technique would also be suitable to characterize the variation between 2B4 expressed by 
different cell lines or primary cells. Furthermore, recent advantages in mass 
spectrometry would be the most powerful method to evaluate glycosylation sites and 
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elucidate the oligosaccharide structures due to its high sensitivity and selectivity (Pan et 
al., 2010).  
The differences between the glycosylation pattern of 2B4 from NK92C1 and other NK 
cells or 2B4-transfected HEK cells could be attributed to N-linked sugars. Hence, it would 
be possible that this bound carbohydrates influence the binding of 2B4 to CD48, too. To 
investigate this, we used tunicamycin, an inhibitor of the GlcNAc phosphotransferase, 
which prevents the transfer of N-acetylglucosamine-1-phosphate from UDP-N-
acetylglucosamine to dolichol phosphate, the first step of N-glycosylation. Tunicamycin 
treated NK92C1 and NKL cells showed diminished killing of CD48 expressing target cells 
which would confirm the essential role of N-glycosylation for 2B4-CD48 interactions. 
However, tunicamycin also had toxic side-effects on NK cells. In NKL cells the reduction 
of cytotoxicity could almost completely be attributed to a diminished viability of 
tunicamycin treated cells as seen by a shift in the forward and side scatter (FSC and 
SSC) population (Figure 23). Furthermore, no mass reduction due to diminished N-
glycosylation could be observed, whereas a reduction of total 2B4 in Western blotting as 
well as a slight reduction of surface expression of the NK cell receptor could be observed. 
Interestingly, NK92C1 cells showed a clear mass reduction of 2B4 down to its calculated 
molecular weight of 40 kDa. Hence, it is hard to say if the reduced killing capacity of 
tunicamycin treated NK92C1 cells is due to successful de-N-glycosylation or if it is only 
due to toxic side effects as seen for NKL cells. Further studies, e.g. using other inhibitors, 
will have to address the exact role of differential N-glycosylation for 2B4 function.  
In contrast to the use of tunicamycin, desialylation of NK cells was successful and 
showed that 2B4 associated sialic acids affect the binding of 2B4 to CD48. Interestingly, 
sialic acids seem to hinder this interaction as we observed increased binding of 2B4 to 
CD48 after Neuraminidase treatment. The negative charge introduced by the addition of 
sialic acids may lead to some repulsion within the 2B4-CD48 interaction, which would 
explain the positive effect on binding upon removal of sialic acids. This effect was not 
only seen in the binding of the recombinant 2B4 fusion protein to CD48 expressing cells, 
but could also be confirmed in NK cells, as Neuraminidase treatment of NK cells resulted 
in enhanced 2B4-mediated lysis of CD48 expressing target cells.  
Our data show that 2B4 is sialylated on N- and O-linked sugars. This would explain why 
the inhibition of O-linked glycosylation in NK cells by BADG also enhanced the lysis of 
CD48 expressing cells and suggest that sialic acids on O-linked sugars are involved in the 
repulsion during the 2B4-CD48 interaction. Removal of sialic acids by Neuraminidase or 
blocking O-linked glycosylation by BADG treatment of NK cells does not only affect the 
glycosylation of 2B4, but affects many different surface molecules and can therefore 
have general effects on NK cell reactivity (Benson et al.). This explains why the treated 
NK cells already show some difference in lysis of Mock–transfected target cells. However, 
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the lysis of CD48-transfected targets was affected to a much larger extent, arguing for a 
specific effect on 2B4-mediated NK cell activation. 
 
The data presented here show for the first time an influence of glycosylation on the 
binding and the functionality of the activating receptor 2B4. The binding of CD8 to MHC-I 
has also been shown to be enhanced upon removal of sialic acids (Daniels et al., 2001) 
and desialylation increases CD8+ T cell sensitivity to APC stimulation (Crespo et al., 
2009). Interestingly, in contrast to naïve T cells, activated T cells show a reduction in 
sialylation (Daniels et al., 2001). Therefore, regulated surface sialylation may play a role 
in regulating T cell responses. No data are available to date about the regulation of 
sialylation in NK cells. However, it is interesting to speculate that a reduced sialylation 
induced by NK cell activation or during NK cell maturation would affect 2B4-mediated NK 
cell activation. Future studies should therefore investigate how the regulation of 
glycosylation could affect NK cell reactivity. 
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7 ABBREVIATIONS 
# number 
 ‘ minute 
α anti (in connection with antibodies) 
ADCC antibody-dependent cellular cytotoxicity 
AICL (CLEC2B) activation-induced C-type lectin 
ANOVA analysis of variance 
APC antigen presenting cells 
BADG Benzyl-2-acetoamido-2-deoxy-α-D-galactopyranoside 
Bat3 human leukocyte antigen-B-associated transcript 3  
BCR B cell receptor  
BVA  Biological Variation Analysis 
CD cluster of differentiation  
CEA carcinoembryonic antigen  
CEACAM1 carcinoembryogenic antigen-related cellular adhesion molecule 1  
CIP calf intestine phosphatase  
CRACC CD2-like receptor-activating cytotoxic cells 
CTXB subunit B of cholera toxin  
DAP DNAX activation protein 
DC dendritic cell 
DIGE difference in gelelectrophoresis 
DNAM-1 DNAX accessory molecule 1 
Dol-P dolichol phosphate 
DRM detergent resistant membrane 
EAT2 Ewing’s sarcoma-associated transcript 2 
EBV Epstein-Barr virus 
ELISA Enzyme-linked immunosorbent assay  
ERM ezrin, radixin and moesin 
ERT EAT-2 related transcript 
ESI  electrospray ionization 
FACS fluorescence-activated cell sorting 
FRET Förster resonance energy transfer  
Fuc L-fucose  
Gal D-galactose  
GalNAc N-acetylgalactosamin  
GDI GDP dissociation inhibitor 
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GEF guanine exchange factor 
Glc D-glucose  
GlcNAc N-acetylglucosamin 
GPI glycosylphosphatidylinositol 
GPT GlcNAc phosphotransferase  
GRB growth factor receptor-bound protein 
GRB2 growth factor receptor-bound protein2 
h hour 
HLA human leukocyte antigen 
IFN interferon 
Ig immunoglobulin 
IL interleukin 
ILZ isoleucin zipper 
IS immunological synapse 
ITAM immunoreceptor tyrosine-based activation motif 
ITIM immunoreceptor tyrosine-based inhibition motif 
ITSM immunoreceptor tyrosine-based switch motif 
IU international unit 
kDa kilo dalton 
KIR killer cell immunoglobulin-like receptors 
LAT linker for activation of T cells  
lo liquid-ordered 
mAb monoclonal antibody 
MALDI matrix-assisted laser desorption/ionization 
Man D-mannose 
MFI  mean fluorescence intensity 
MHC major histocompatibility complex 
MIC MHC class I related chain  
min minute 
MS mass spectrometry 
NCR natural cytotoxicity receptor 
Neu5Ac sialic acid 
NK cell natural killer cell 
NKIS NK cell immunological synapse 
NTB-A NK, T, B cell antigen 
PAGE polyacrylamide gel electrophoresis 
PLC phospholipase C 
PNGase Peptide: N-Glycosidase 
POI protein of interest  
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PVR poliovirus receptor 
rER rough endoplasmic reticulum 
Rho GDI Rho GDP dissociation inhibitor beta 
SA sialic acid 
SAP SLAM-associated protein 
SDS sodium dodecyl sulfate 
SH2 Src homology 2 
SHIP SH2-domain containing inositol-phosphatase 
SHP-1/2 SH2-domain containing phosphatase 1/2 
Siglec sialic-acid-binding immunoglobulin-like lectins  
SLAM signaling lymphocyte activation molecule 
SMAC supramolecular activating cluster  
SMIC supramolecular inhibition cluster 
SRR SLAM-related receptor 
STED stimulated emission depletion 
TAP transporter associated with antigen processing 
TCR T cell receptor 
TM tunicamycin 
TNF tumor necrosis factor 
TRAIL TNF-related apoptosis inducing ligand 
U unit 
ULBP UL-16 binding protein  
WB Western blot 
XLP X-linked lymphoproliferative disease 
Xyl D-xylose  
 
The single amino acid code was used to describe amino acid residues. 
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8 APPENDIX 
8.1 Table of identified proteins by mass spectrometry 
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 Acc. Nr.g Protein Namek 
          
1 0.012 -1,15 438 262237 6.58 11  gi|58530842 desmoplakin isoform II [Hs] 
   384 114670 4.9 8  gi|119703744 desmoglein 1 [Hs] 
   90 82434 5.75 2  gi|4504811 junction plakoglobin [Hs] 
   84 79830 5.71 2  gi|516764 motor protein [Hs] 
   67 22014 6.84 3 f gi|438069 thiol-specific antioxidant protein [Hs] 
   60 67172 8.72 2 f gi|68563515 keratinocyte proline-rich protein [Hs] 
   27 22324 8.27 1  gi|4505591 peroxiredoxin 1 [Hs] 
   32 93668 5.26 1  gi|457464 Dsc1a precursor [Hs] 
          
2 0.021 1,38 236 74118 6.46 5  gi|21614499 ezrin [Hs] 
   39 78166 5.88 1  gi|600727 glycyl tRNA synthetase [Hs] 
   35 28476 6.82 1  gi|110077 immunoglobulin gamma-chain [Mm] 
          
3 7.1x10-4 2,44 39 58262 5.90 1  gi|4584820 protein phosphatase 3, catalytic subunit, alpha isoform isoform 1 [Hs] 
   34 57044 6.38 2 f gi|303618 phospholipase C-alpha [Hs] 
          
4 1.8x10-3 1,54 460 57794 6.01 14  gi|5453603 chaperonin containing TCP1, subunit 2 [Hs] 
   281 33345 5.45 7  gi|8439415 tryptophanyl-tRNA synthetase [Hs] 
   261 56578 7.14 7  gi|4557817 3-oxoacid CoA transferase 1 precursor [Hs] 
   240 57421 5.96 7  gi|3273316 UDP-N-acetylglucosamine pyrophosphorylase [Hs] 
   117 28476 6.82 3  gi|51653 immunoglobulin gamma-chain [Mm] 
   54 58000 5.83 1  gi|5453980 DnaJ (Hsp40) homolog, subfamily C, member 3 [Hs] 
   48 12394 8.88 1  gi|110301 immunoglobulin heavy chain variable region [Mm] 
   47 57624 6.37 2 f gi|11559925 X-prolyl aminopeptidase (aminopeptidase P) 3, putative [Hs] 
          
5 4.9x10-3 7,66 63 28476 6.82 2 f gi|51653 immunoglobulin gamma-chain [Mm] 
   49 12394 8.88 1  gi|110301 immunoglobulin heavy chain variable region [Mm] 
   41 50055 4.81 1  gi|35959 tubulin 5-beta [Hs] 
   39 49484 5.89 1  gi|5031753 heterogeneous nuclear ribonucleoprotein H1 [Hs] 
   39 71316 6.05 1  gi|28592 serum albumin [Hs] 
   35 44534 6,43 1  gi|239552 squamous cell carcinoma antigen 1 [Hs] 
          
6 9.6x10-3 -1,29 581 56226 6.44 19  gi|66933016 inosine monophosphate dehydrogenase 2 [Hs] 
   57 11006 9.34 2 f gi|61608473 immunoglobuliln heavy chain variable region [Hs] 
   53 54886 7,21 1  gi|118674 dihydrolipoamide dehydrogenase [Hs] 
   31 52143 9.25 1  gi|487420 Semenogelin I [Hs] 
          
7 0.035 1,50 514 51693 5.70 14  gi|4758384 FK506 binding protein 5 [Hs] 
   396 53088 5.58 13  gi|8922699 CNDP dipeptidase 2 [Hs] 
   309 49484 5.89 9  gi|5031753 heterogeneous nuclear ribonucleoprotein H1 [Hs] 
   108 57753 5.97 3  gi|5453603 chaperonin containing TCP1, subunit 2 [Hs] 
   63 56066 5.44 1  gi|149589008 peptidase D [Hs] 
   57 28476 6.82 1  gi|51653 immunoglobulin gamma-chain [Mm] 
          
8 0.043 -1,17 MS: 91 55574 9,4 19%  gi|119617402 serine hydroxymethyltransferase 2 (mitochondrial), isoform 
          
9 0.027 1,14 MS: 101 18259  53%  gi|119591666 septin 2, isoform CRA_c [Hs] 
          
10 7.2x10-3 -1,16 63 36297 6.49 2 f gi|3377279 heterogeneous nuclear ribonucleoprotein A/B isoform a [Hs] 
          
11 0.045 1,16  23031 4,9 52%  gi|56676393 Rho GDP dissociation inhibitor (GDI) beta [Hs] 
          
12 7.9x10-3 1,27  28469 4,9 25%  gi|4502565 calpain, small subunit 1 [Hs] 
          
13 1.8x10-4 -2,06 393 25133 6.00 11  gi|4758638 peroxiredoxin 6 [Hs] 
   142 24361 8.29 5  gi|11139093 GrpE-like protein cochaperone [Hs] 
   78 27811 6.34 2  gi|123997751 proteasome (prosome, macropain) subunit, alpha type, 6 [Hs] 
   66 27021 6.90 2 f gi|17389815 Triosephosphate isomerase 1 [Hs] 
   64 12098 5.60 1  gi|52120 immunoglobulin kappa light chain [Mm] 
   38 114702 4,9 1  gi|416917 desmoglein 1 [Hs] 
   188 25133 6.00 6  gi|4758638 peroxiredoxin 6 [Hs] 
          
14 5.3x10-5 -5,60 102 23583 5.43 2  gi|726098 glutathione S-transferase-P1c [Hs] 
   42 26180 8.14 1  gi|7706497 cytidine monophosphate (UMP-CMP) kinase 1, cytosolic isoform a [Hs] 
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15 1.0x10-4 7,29 134 23596 6.18 3  gi|7657033 5',3'-nucleotidase, cytosolic [Hs] 
   71 12098 5.60 1  gi|52120 immunoglobulin kappa light chain [Mm] 
          
16 3.5x10-4 4,44 147 27134 7.66 4  gi|4758504 hydroxysteroid (17-beta) dehydrogenase 10 isoform 1 [Hs] 
   146 57578 5.82 5  gi|169170768 keratin 8 [Hs] 
   112 12098 5.60 10  gi|52120 immunoglobulin kappa light chain [Mm] 
   117 61187 5.60 2  gi|31542947 chaperonin [Hs] 
   98 27134 5.70 3  gi|4758504 hydroxysteroid (17-beta) dehydrogenase 10 isoform 1 [Hs] 
   92 14847 7.66 1  gi|37848 vimentin [Hs] 
   73 15256 10.14 1  gi|90831 Ig kappa chain precursor V region (4C11) - mouse (fragment) 
   70 50437 9.00 5 f gi|31092 eukaryotic translation elongation factor 1 alpha 1 [Hs] 
   36 71316 10.87 1  gi|28592 serum albumin [Hs] 
          
17 6.6x10-5 4,77 105 24835 6.05 2  gi|180637 protein-L-isoaspartate (D-aspartate) O-methyltransferase [Hs] 
   77 12098 5.60 4 f gi|52120 immunoglobulin kappa light chain [Mm] 
   94 57753 5.97 1  gi|468546 chaperonin containing TCP1, subunit 2 [Hs] 
   93 28467 8.50 4 f gi|1545813 KNP-Ia [Hs] 
   60 50437 9.10 1  gi|31092 eukaryotic translation elongation factor 1 alpha 1 [Hs] 
   59 12098 5.60 1  gi|52120 immunoglobulin kappa light chain [Mm] 
   40 39193 5.26 1  gi|27806751 alpha-2-HS-glycoprotein [Bos taurus] 
   40 59004 5.48 1  gi|51452 chaperonin [Hs] 
   33 25188 5.37 1  gi|162805 beta-casein [Bos taurus] 
          
18 0.019 1,16 255 26023 8,39 4  gi|1709759 Proteasome subunit alpha type-2 [Hs] 
   238 24835 6.05 4  gi|180637 L-isoaspartyl/D-aspartyl protein carboxyl methyltransferase [Hs] 
   93 50437 9.10 2 f gi|31092 eukaryotic translation elongation factor 1 alpha 1 [Hs] 
   42 59004 5.48 1  gi|51452 chaperonin [Hs] 
   34 57753 5.97 1  gi|468546 chaperonin containing TCP1, subunit 2 [Hs] 
          
19 0.023 1,27 MS: 106 23555 5,3 48%  gi|2554831 Chain A, Crystal Structure Of Human Glutathione S-Transf  
          
20 0.032 1,13 MS: 95 17401 9,4 51%  gi|4505409 non-metastatic cells 2, protein (NM23B) expressed in  
          
21 6.2x10-6 -4,51 244 29298 7.86 9  gi|2623274 MHC class II antigen [Hs] 
   175 23655 6.31 9  gi|4504111 growth factor receptor-bound protein 2 isoform 1 [Hs] 
   163 24361 8.29 8  gi|11139093 GrpE-like protein cochaperone [Hs] 
   123 11433 8.65 4  gi|50540932 MHC class II antigen [Hs] 
   109 12098 5.60 9  gi|52120 immunoglobulin kappa light chain [Mm] 
   244 29298 7,86 9  gi|22538467 proteasome beta 4 subunit [Hs] 
   95 27134 7.66 2  gi|4758504 hydroxysteroid (17-beta) dehydrogenase 10 isoform 1 [Hs] 
   72 24835 6.05 2 f gi|180637 protein-L-isoaspartate (D-aspartate) O-methyltransferase [Hs] 
   70 35807 8.57 2 f gi|4929649 CGI-90 protein [Hs] 
   66 27329 5.95 1  gi|37460 unnamed protein product [Hs] 
   49 9031 8.12 1  gi|110230 immunoglobulin light chain variable region [Mm] 
          
22 1.6x10-3 3,95 MS: 116 62255    gi|55956899 keratin 9 [Hs] 
          
23 1.8x10-3 2,72 MS: 91 53474 5,8 27%  gi|47419914 tryptophanyl-tRNA synthetase isoform a [Hs] 
          
   318 53088 5.58 11  gi|15620780 glutamate carboxypeptidase [Hs] 
   131 49484 5.89 2  gi|5031753 heterogeneous nuclear ribonucleoprotein H1 [Hs] 
   109 51693 5.70 4  gi|4758384 FK506 binding protein 5 [Hs] 
   108 28476 6.82 5  gi|121040 immunoglobulin gamma-chain [Mm] 
   65 12098 5.60 2 f gi|52140 immunoglobulin kappa light chain [Mm] 
   48 12394 8.88 1  gi|110301 Ig heavy chain V-D-J region (106-10E) - mouse (fragment) 
   39 24318 5.30 1  gi|30794348 casein alpha s1 [Bos taurus] 
   37 36202 8.26 1  gi|31645 glyceraldehyde-3-phosphate dehydrogenase [Hs] 
 
ap value calculated using the Student’s T-test.  
bAverage ratio between 2B4 and NKG2A (>1  greater extend in the 2B4 samples; <-1 greater  
  extend in the NKG2A samples.  
cProbability-based Mascot scores 
dTheoretical molecular mass (Da) and pI from the ExPASy database. 
eNumber of hits resulting from ESI analysis. Percent values indicates sequence coverage of MALDI 
  analysis. 
fSingle peptidscore non-significant, sum of singlescores significant. 
gAccession number derived from PubMed. 
kProtein name derived from PubMed. [Hs] means homo sapiens [Mm] means mus musculus.   
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